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Abstract 
Introduction: 
Oral candidiasis is prevalent among older people due to predisposing factors such as 
impaired immune defences, medications and denture use. An increasing number of older 
people live in rest home facilities and it is unclear how this institutionalised living affects 
the quantity and type of fungi colonizing these people’s oral cavities. 
Objective:  
The aim of this study was to investigate the presence and abundance of yeast species and 
Candida albicans strains in saliva and from the oral mucosal swabs and smears of older 
people living in rest homes and those living at home. 
Methods: 
Smears and swabs of the palate and tongue, and saliva samples were taken from 
participants residing in rest homes (RH; n = 25) and older people living in their own 
homes (OH; n = 25). Yeast in samples were quantified and presumptively identified by 
culturing on CHROMagar Candida agar. Sequencing of the ITS2 region of rDNA was 
carried out to confirm yeast species. Multilocus sequence typing (MLST) of seven 
housekeeping genes was used to compare Candida albicans strains. 
Results: 
A higher proportion of RH residents had Candida hyphae present in smears compared to 
OH participants (35% vs. 30%) although this difference was not statistically significant 
(p = 0.74). RH residents had, on average, 23 times as many yeast per mL saliva as OH 
participants (p = 0.01). Seven yeast species were identified in OH samples and only five 
in RH samples, with C. albicans and C. glabrata being the most common species isolated 
from both participant groups. MLST analysis of 87 C. albicans strains revealed 34 
different diploid sequence types (DST). Participants with normal saliva flow tended to 
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have one C. albicans strain at all three sample sites (palate, tongue, saliva). Participants 
with low salivary flow rates also appeared to have mostly the same C. albicans strain at 
all three sample sites. For these strains, however, there was evidence of gene 
variation including loss of heterozygosity and aneuploidy which may be an indication of 
strain adaptation to the altered oral environment. Nine strains, found in four rest home 
participants, appeared to be C. albicans/Candida dubliniensis chimeras (hybrid strains). 
Conclusion: 
The results indicate that communal living for those who reside in an age care facility has 
an impact on the abundance of yeast species and the prevalence of chimera strains. This 
may be due to morbidities which led to the need for residential care and/or related to the 
rest home environment. 
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Chapter 1: Introduction  
 
1.1 Introduction 
 
The oral cavity is colonized by hundreds of different microorganisms that form complex 
microbial communities. Most of these communities are present in biofilms on various 
oral surfaces. The immune system of healthy individuals maintains stable biofilm 
communities that help prevent oral infections. Impaired immune defences can cause an 
imbalance of the microbiota, or dysbiosis, and lead to bacterial, viral or fungal infections. 
Candida species are a normal component of the oral microbiota (Cannon & Chaffin, 
1999b) that are carried in the mouths of about 40%-60% of healthy individuals (Zegarelli, 
1993). C. albicans is the most prevalent species (Cannon, Holmes, Mason, & Monk, 
1995)(Meurman et al., 2011) and non-albicans Candida species, for example, Candida 
glabrata, Candida tropicalis, Candida parapsilosis, and Candida krusei may be found 
in mouths of healthy individuals (Odds, 1988). Other species such as Candida 
guilliermondii, Candida kefyr, Candida rugosa, Candida dubliniensis, and Candida 
famata have also been reported, but less frequently (López-Martínez, 2010)(Miceli, Díaz, 
& Lee, 2011).  
Oral candidiasis is the most common type of fungal infection of the oral cavity and C. 
albicans is the most frequent cause as it is a commensal microorganism (Nobile & 
Johnson, 2015). A provisional diagnosis of candidiasis can be made based on the medical 
history of the individual and oral examination of presenting signs and symptoms. This 
diagnosis can be confirmed histologically by demonstrating the presence of hyphae in 
mucosal smears (Guarner & Brandt, 2011). Patients with oral candidiasis can be treated 
with antifungal agents such as polyenes (e.g. amphotericin B and nystatin) and azole 
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derivatives (e.g. fluconazole, ketoconazole, clotrimazole, and miconazole). It has been 
reported that 20% of patients with oral candidiasis experience recurrence of infection, 
and around 30% of the recurrences were caused by Candida strains different from the 
first episode of infection (Gallè et al., 2011). Candida species differ in their susceptibility 
to antifungal agents. C. glabrata and C. krusei show reduced sensitivity to azoles 
(Meurman et al., 2011; Sanguinetti, Posteraro, & Lass-Flörl, 2015) and Candida 
lusitaniae can develop resistance to amphotericin B (Atkinson, Lewis, & Kontoyiannis, 
2008). In addition, C. parapsilosis has been reported to cause outbreaks of candidemia 
in immunocompromised patients in hospital settings (Marconi et al., 2016) where it was 
thought to be transmitted by the hands of health care workers.  
Factors that predispose to candidiasis include systemic factors caused by drug therapy 
(e.g. broad-spectrum antibiotics, corticosteroids)(Barbe, 2018), reduced saliva flow, 
chronic disease processes, malnutrition, immunosuppression, and neoplasia in addition 
to local factors including wearing dentures overnight, ill-fitting dentures and poor 
prosthesis hygiene (Razak et al., 2014). In the oral cavity, components of the innate 
immune system, such as salivary flow and biological components within saliva, play a 
major role in preventing infections (Humphrey & Williamson, 2001). Factors that reduce 
saliva flow predispose to infections such as candidiasis. In studies of people with 
xerostomia (dry mouth), it has been shown that there is an inverse correlation between 
salivary flow rate and the number of Candida cells in oral samples (Shinozaki et al., 
2012)(Nadig et al., 2017). There was also an inverse correlation between the salivary 
flow rate and the severity of oral candidiasis (Shinozaki et al., 2012). Xerostomia can be 
induced by a large number of medications and older people often are prescribed multiple 
medications. Denture wearing increases with age and dentures obstruct saliva flow across 
mucosal surfaces. This reduces the clearance of microbes and creates environments that 
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promote fungal growth. Therefore, it is not surprising that older people are more likely 
than younger people to have oral mucosal lesions, including candidiasis (Lynge 
Pedersen, Nauntofte, Smidt, & Torpet, 2015). 
Populations worldwide are ageing. The World Health Organization (WHO) estimates 
that by 2050 the proportion of the population that is ‘older’ (above the age of 60) will 
have increased from 12% in 2015 to 22%, that is, from 900 million to 2 billion people 
(WHO factsheet/Ageing and health, 2018). Studies have shown that elderly patients 
living in institutional care facilities such as nursing homes and hospitals are more 
susceptible to oral and systemic Candida infections (Dimopoulos, Flevari, 
Theodorakopoulou, Velegraki, & Armaganidis, 2013), mainly due to comorbidities, in-
dwelling devices, and common care facility processes, for example diet and oral care 
practices.  It is important to know the types of Candida species colonizing the older 
community especially individuals in institutionalized settings as there is a variety of 
resistant species which may be a threat to health. What is concerning is the emergence of 
non-albicans Candida strains with lower antifungal susceptibility in self-caring, nursing 
home residents (Meurman et al., 2011). The presence of resistant Candida species could 
pose a problem for older people if they become immune compromised and develop 
candidiasis.  
As many older people now live in residential aged care facilities, the aim of this study 
was to compare the Candida species colonizing the oral cavities of people living in rest 
homes with those living in their own homes.  
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1.2 Literature Review 
 
1.2.1 Older Population 
An older person is someone who has passed middle age and is approaching old age. The 
New Zealand population is ageing, 14.2% of the population are above the age of 65, and 
this number is expected to increase to 26.7% (about 1 in 4 people) by 2063 (Statistics 
New Zealand, 2014). This reflects the ageing trend of the world population. The United 
Nations estimated that the number of people above the age of 60 will double from 962 
million in 2017 to 2.1 billion in 2050  (UN-DESA, 2017). The increased proportion of 
older people in the population is due to declining birth rates, increasing longevity and 
improvements in survival from accidents and disease.  
 
The process of ageing is often associated with a decline in physical, sensory or cognitive 
capacity. The older person may be affected by chronic diseases that require them to take 
medications, undergo treatment like chemotherapy or radiotherapy which contribute to 
ongoing disability, variable levels of frailty, dependency and a reduction in quality of 
life. There is a dynamic and complex relationship between poor oral health and frailty. 
Poor oral health may affect nutritional intake which can lead to lethargy, frailty, illness 
and other health issues.  
 
Half of the older people living in New Zealand reside in residential care (Broad et al 
2015), which was about 32,000 people in 2013 (Statistics New Zealand, 2014). 
Residential care refers to long-term care (hospital-based, dementia unit, or rest home) 
given to individuals who live in a residential setting rather than in their own home. Often 
members of this population do not routinely engage in oral health care practices which 
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would assist in reducing oral disease and maintaining oral health (M. B. Smith, Thomson, 
& Gribben, 2012).  
  
Specific physiological characteristics of older populations (e.g. use of multiple 
medications and dry mouth) make them more susceptible to colonization and infection 
by Candida species (Watanabe, 2014)(Dimopoulos, Flevari, Theodorakopoulou, 
Velegrak 2013). Dry mouth is more common among older people, as is a higher 
prevalence of yeast carriage in individuals with dry mouth (Thomson, 2015)(Hou, 
2012)(Meurman et al., 2011). Studies have shown that older patients living in 
institutional care facilities are more susceptible to oral and systemic Candida infections 
(Grimoud et al., 2005)(Dimopoulos, Flevari, Theodorakopoulou, Velegraki, & 
Armaganidis, 2013). Superficial oral Candida infections which are not well managed in 
elderly or immunosuppressed patients, have the potential to spread.  
 
 
1.2.2 Candida 
Candida is a genus of yeast found in the oral cavity, gastrointestinal tract and 
genitourinary tract and on the skin where they are usually benign but can become 
pathogenic. The taxonomy of Candida is a complex subject as, historically, the genus 
Candida was defined as fungi able to form hyphae or pseudo-hyphae and reproduce by 
mitotic division (asexually). Analysis has since found that Candida species actually 
represent a polyphyletic group derived from more than one common evolutionary 
ancestor that are able to reproduce by both sexual and asexual modes. Many species have 
retained the ‘Candida’ name even when proven to have a sexual form, for example, 
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Candida tropicalis and Candida krusei. Thus, the genus name ‘Candida’ may be 
misleading as Candida species can be very different from one another. 
 
Candida belongs to the Saccharomycotina sub-phylum which is a subdivision of the 
Ascomycota phylum within the Kingdom Fungi. The Saccharomycotina sub-phylum 
comprises an estimated 807 species of eleven distinct clades (Hittinger et al., 2015). Most 
of the important ‘Candida’ species belong to four major clades: 
i) Candida CTG (217 species; including C. albicans, C. dubliniensis, C. tropicalis, 
C. parapsilosis, C. guilliermondii, C. lusitaniae, C. famata, and C. rugosa) that 
translate CTG codons as serine instead of the usual leucine.  
ii) Saccharomycetaceae (~129 species) including C. kefyr and the post Whole 
Genome Duplication (WGD) species C. glabrata and S. cerevisiae 
iii) Pichiaceae (~134 species) including C. krusei and C. inconspicua   
iv) Phaffomycetaceae (~92 species) including C. norvegensis 
A clade is a group of organisms originating from a common ancestor, and their lineal 
descendants and represents a branch in the phylogenetic tree. As the population evolves, 
the branch splits into smaller branches reflecting evolutionary history. Species within the 
same clade do share some features, for example, species in the Candida CTG clade have 
a distinctive codon usage. However, each species is unique and genetically distinct from 
each other.  
  
1.2.3 Candida albicans 
Worldwide, invasive candidiasis affects more than 250,000 people every year, causing 
the deaths of more than 50,000 and C. albicans accounts for half the isolates detected 
(Kullberg & Arendrup, 2015). C. albicans is an opportunistic pathogen residing 
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harmlessly on the body as a commensal. Fungal proliferation is kept under control by the 
host immune system and a protective bacterial microbiome of the gut and other mucosal 
surfaces (Cheng, Joosten, Kullberg, & Netea, 2012a). C. albicans is able to thrive in 
different parts of the body (gut, vagina, oral mucosa, skin) without causing disease 
(Nobile & Johnson, 2015). It is a very flexible and adaptable organism in its capacity for 
survival in and on the human body.  
 
1.2.3.1 Characteristics of Candida albicans 
C. albicans is a polymorphic organism, as it is able to grow as ovoid, unicellular, yeast 
cells (sometimes referred to as blastospores), filamentous hyphae, pseudo-hyphae with 
constricted septa and thick-walled chlamydospores (Odds, 1988). However, novel cell 
morphotypes, opaque (a/a), grey and gastrointestinal induced transition (GUT) cell 
types, have recently been reported, further complicating our understanding of host-
Candida interactions of commensalism and disease (Noble, Gianetti, & Witchley, 2017). 
The morphological changes between these growth forms are stimulated by environmental 
conditions such as temperature, pH, concentration of CO₂ and glucose. Yeasts propagate 
by mitotic division in favourable growth conditions forming clonal populations of 
haploid, diploid and/or polyploid cells (Dujon, 2010). Some species, such as 
Saccharomyces cerevisiae, have the ability to undergo a complete sexual cycle. C. 
albicans has the genes necessary for most stages of a sexual cycle but is thought to only 
undergo sexual reproduction rarely.  
 
The C. albicans genome consists of a 16 megabase (haploid) genome organized in 8 
mostly heterozygous diploid chromosomes (Selmecki, Forche, & Berman, 2010) . It 
reproduces by asexual clonal division, as well as mating between cells of the opposite 
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mating type and undergoes a parasexual cycle. In this cycle, diploids mate forming 
tetraploids which then undergo sequential chromosome loss, producing near-diploid 
progeny that are often trisomic and/or homozygous for one or more whole chromosomes. 
The C. albicans genome has a high level of plasticity; it is capable of undergoing genomic 
changes like gross chromosomal rearrangements, aneuploidy, and loss of heterozygosity 
(LOH) under stressful conditions like extreme temperatures, nutrient deficiency and 
exposure to chemotherapeutic or antifungal drugs (Forche et al., 2011). LOH is a genetic 
event during mitotic division resulting in daughter cells that are homozygous in one or 
more alleles. This may be due to mitotic recombination, gene conversion or deletion. The 
range of LOH may be short tracts (≤10 kb), long tracts (>10 kb) or whole chromosomes 
(Forche et al., 2011). Aneuploidy is the presence of an abnormal number of chromosomes 
– instead of two copies of each chromosome, there may be only one copy or three or 
more copies of particular chromosomes. Aneuploidy can occur in a cell when there is 
LOH of a whole chromosome. Aneuploidy is generally disadvantageous as it often 
uncovers recessive detrimental mutations. However, some aneuploidies provide a fitness 
advantage where cells that retain the more beneficial allele after LOH may exhibit a 
growth advantage under stressful conditions over cells that do not undergo LOH 
(Wertheimer, Stone, & Berman, 2016). 
  
   
Yeast cell growth is favoured by relatively low temperatures (~30°C), acidic pH and the 
absence of serum. Growth of yeast cells allows for the dissemination of the organism to 
other sites. The transition of yeast to hyphal growth is triggered by many nutritional and 
environmental factors, including the presence of serum, neutral pH, relatively high 
temperatures (37˚C), nutrient starvation, hypoxia and high concentrations of CO₂ (Lu, 
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Su, & Liu, 2014). The hyphal form is crucial in the infection process, as it enables tissue 
penetration and escape from immune cells. The morphological plasticity of C. albicans 
is a critical factor in its pathogenicity both superficially and systemically. 
 
Phenotypic switching in C. albicans is referred to the spontaneous, reversible, white to 
opaque cell-type switching system (Noble et al., 2017). The switch changes the cell 
morphology (size and shape of cells), giving the organism the ability to form hyphae, 
improve adhesion, change its membrane composition, differ the range of secretory 
products, reduce sensitivity to neutrophils and oxidants, antigenicity and drug 
susceptibility (Soll, 2014). White cells are round or ovoid and form smooth, domed 
colonies. They secrete a chemoattractant for leukocytes, express genes involved in 
fermentative metabolism, they are not competent for mating and are more virulent in 
systemic candidiasis compared to the larger opaque cells. Opaque cells are bean-shaped, 
the surface is covered with pimples and they form flat translucent colonies. The cells are 
resistant to neutrophil engulfment, express genes involved in oxidative metabolism and 
mate more efficiently than white cells (Bommanavar, Gugwad, & Malik, 2017). 
 
1.2.3.2 Factors associated with antifungal resistance and virulence in Candida albicans 
Adhesion 
Candida species have the ability to adhere tightly to different surfaces, either biological 
or inert abiotic surfaces. Adhesion is the important first step in the attachment and 
proliferation of cells and the establishment of fungal infections. C. albicans adhesins are 
cell wall proteins, the three major groups are encoded by the ALS, HWP, and IFF/HYR 
gene families. The ability of conformational activation of adhesins, differential gene 
expression patterns, and allelic variability of these gene families, make C. albicans highly 
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adaptable in its adhesion to different surfaces (Cavalheiro & Teixeira, 2018) . Candida 
adhesion to other Candida cells or other microbes leads to the formation of biofilms of 
either multi- or mono-species communities (de Groot, Bader, de Boer, Weig, & Chauhan, 
2013).  
 
Biofilm formation 
C. albicans biofilms are composed of cells in different morphologies encased in an 
extracellular matrix. These biofilms have been found on endothelial cells, epithelial 
mucosal tissues, urinary and central venous catheters, pacemakers, mechanical heart 
valves, joint prostheses, contact lenses, and dentures. Biofilms have the potential to seed 
disseminated bloodstream infections and lead to invasive systemic infections of tissues 
and organs. Biofilm formation comprises four stages: (a) adherence to a surface (usually 
by yeast cells); (b) proliferation forming a basal layer of cells; (c) growth of 
pseudohyphae and hyphae along with production of extracellular matrix material; and (d) 
slow dispersal of yeast-form cells from the biofilm to seed new sites (Nobile & Johnson, 
2015). Complex interspecies interactions occur within polymicrobial biofilms which 
pose a significant clinical challenge as they are resistant to conventional antimicrobial 
therapy, the host immune system, and other environmental interventions. Factors which 
contribute to the antifungal resistance of biofilms are the extracellular matrix which acts 
as a barrier to drug diffusion, alterations in gene expression during biofilm formation (e.g 
upregulation of CDR and MDR genes encoding azole drug transporters) and the presence 
of biofilm persister cells which display resistance to fluconazole (Cavalheiro & Teixeira, 
2018). The cell wall of C. albicans is a dynamic structure which provides protection 
against physical and chemical insult, is responsible for the different shapes displayed by 
C. albicans and plays an important role in interactions with host tissues. The cell wall is 
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mainly composed of proteins, glucans, and chitin. The inner layer of the cell wall appears 
translucent under transmission electron microscopy (TEM) and is composed of a chitin 
and polysaccharide matrix. The outer layer is enriched with mannoprotein and appears 
denser under TEM and has perpendicularly aligned fibrils that are mostly mannoproteins 
(Chaffin, 2008). The ability of C. albicans to alter its cell wall architecture and 
composition determines the cell morphology and enables its evasion of the host immune 
system (Chaffin, 2008). The main structural component of the C. albicans cell wall is b-
1,3-glucan (Ene et al., 2012). The glucan composition of the wall determines the 
organism’s sensitivity to environmental stress and antifungals (da Silva Dantas et al., 
2016). Cell wall polysaccharide interacts with pattern recognition receptors on host cells 
stimulating an immune response. Altering the expression and presentation of critical 
polysaccharide pathogen-associated molecular patterns (PAMPs) reduces the detection 
of C. albicans by neutrophils (Chaffin, 2008)(da Silva Dantas et al., 2016).  
 
Enzyme secretion 
C. albicans secretes hydrolytic enzymes which possess a range of functions including 
degradation of host connective tissues, nutrient acquisition and evasion of the host 
immune system (da Silva Dantas et al., 2016). The hydrolytic enzymes are secreted 
aspartic proteinases (Saps), secreted phospholipases (PLs) and lipases (Lips). The C. 
albicans Sap family comprises 10 proteins, each functioning optimally at different pH, 
temperatures, and acting on different carbon and nitrogen sources (Schaller, Borelli, 
Korting, & Hube, 2005). 
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Sugar sensing 
Nutrients in the form of glucose, fructose, mannose and N-acetyl glucosamine (GlcNAc) 
are important for Candida growth (Lu, Su, & Liu, 2014). C. albicans has a unique sugar 
sensing and signalling system involving the glucose transporter gene family consisting 
of 20 high-affinity glucose transporters. Each transporter/sensor is unique to a specific 
type of sugar and concentration level. C. albicans HGT9, HXT10, HGT12, and HGT17 
are strongly expressed at low glucose concentrations (0.2%) and repressed at 5% glucose 
while other HGT genes are expressed in 2% glucose. C. albicans GAL1, GAL7, GAL10 
are involved in sensing galactose and Hgt4 is the sensor for fructose and mannose. 
HGT12 and HGT7 encode transporters for fructose and mannose (Van Ende, Wijnants, 
& Van Dijck, 2019). GlcNAc is transported into the cells and metabolized into fructose-
6-phosphate, which is further metabolized to pyruvate. Studies suggest that GlcNAc 
induces galactose absorption by C. albicans (Chaffin, 2008). C. albicans is capable of 
utilising different carbon sources simultaneously in the presence of glucose making it 
adaptable to dynamic changes within the host (Van Ende et al., 2019). 
 
1.2.4 Candidiasis 
Candidiasis is the term for fungal infections caused by Candida. Candidiasis may occur 
in the oral cavity, in the gastrointestinal tract, on the skin, or in the genitourinary tract. It 
can manifest as a topical or systemic disease.  Oral candidiasis is the most common type 
of opportunistic infection of the oral cavity, and C. albicans is the most frequent cause 
of this condition (Nobile & Johnson, 2015). 
 
Colonization by Candida depends on the entry of cells into the oral cavity, attachment 
and growth, tissue penetration and cell removal/clearance from the oral cavity (Cannon 
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& Chaffin, 1999a) and that rates of replication at least match the rate of clearance. 
Clearance of Candida from the oral cavity is achieved by swallowing and oral hygiene. 
Colonization by Candida does not signify oral disease. Candidiasis occurs when 
replication exceeds clearance and there is the presence of tissue damage. 
 
Candida is acquired by manual transmission, saliva transfer or contaminated food and 
drink (Fanello, Bouchara, Jousset, Delbos, & LeFlohic, 2001). To colonize the oral 
cavity, the Candida cells utilise cell wall adhesins to adhere to the host surfaces 
(Cavalheiro & Teixeira, 2018). Adhesins are molecules which enable binding of Candida 
cells to oral epithelial cells, saliva molecules, teeth, other organisms, and dentures (de 
Groot et al., 2013). The adhesins found on the cell wall of C. albicans are highly specific 
in promoting adhesion to different types of surface, in aggregation, biofilm formation, 
and modulating host immune responses. ALS-like genes have been found in non-albicans 
Candida C. dubliniensis, C. tropicalis, C. parapsilosis, C. lusitaniae, and C. 
guilliermondii while IFF/HYR gene families have been identified in CTG-clade Candida 
species. C. glabrata contains Epa adhesins which bind to epithelial and endothelial cells, 
and innate immune cells (de Groot, Bader, de Boer, Weig, & Chauhan, 2013). 
 
Glucose functions as the building block for the synthesis of other biomolecules as well 
as for energy production via fermentation or respiration. Glucose may also be a ligand 
for receptors or a substrate for transporters (Van Ende, Wijnants, & Van Dijck, 2019). In 
a nutrient-rich environment, C. albicans maintains its yeast form. C. albicans exhibit 
increased resistance to azole antifungal drugs and osmotic stress in the presence of 
increased glucose concentrations (0.01–1%) due to upregulation of stress resistance 
genes (Ene et al., 2012). Patients with diabetes are reported to be more susceptible to 
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systemic Candida infection as C. albicans cells respond to glucose in the bloodstream by 
increasing their resistance to oxidative and cationic stresses  (Rodaki et al., 2009).  
Candidiasis is also more prevalent in patients with poor oral/denture hygiene and dry 
mouth as the latter reduces saliva diluting oral sugars (Billings, Dye, Iafolla, Grisius, & 
Alevizos, 2017). Candida competes for glucose with other organisms in the oral cavity 
and proliferate in the absence of bacteria as seen in long term antibiotic use (Cannon & 
Chaffin, 1999). 
 
After colonization, the next step in the pathophysiology of candidiasis is host tissue 
invasion. C. albicans hyphae invade the epithelial via active tissue penetration (epithelial 
attachment, tissue invasion, and tissue damage)(Cannon et al., 1995). C. albicans can 
also spread passively via induced endocytosis, whereby viable and dead C. albicans cells 
are engulfed by epithelial cells. Within the epithelial cells, viable C. albicans cells form 
hyphae, which can pierce the cells via the action of the EED1 gene (epithelial escape and 
dissemination 1). C. albicans is also able to downregulate epithelial TLR4 expression, 
increasing the vulnerability of epithelial cells to C. albicans infection (Cheng, Joosten, 
Kullberg, & Netea, 2012b). 
 
1.2.4.1 Factors predisposing to oral candidiasis 
Prostheses 
Prostheses with poor retention or stability cause irritation which can lead to local 
microscopic breaches of the oral mucosa, allowing the organism access into the host 
tissues (Farah, Amos, Leeson, & Porter, 2018). Poor denture hygiene allows biofilm 
development which can act as a reservoir of Candida cells. Due to the poor salivary flow 
adjacent to the fitting surface of the denture, this region has a low oxygen tension and 
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low pH, favouring yeast proliferation. A higher percentage of denture wearers (64.2%) 
had Candida carriage compared to non-denture wearers (19.2%) (Pereira Lyon et al., 
2006). Worn-down dentures cause reduced vertical dimension which increases the 
wrinkling/creasing of the commissures of the lips. Stagnation of saliva in this region 
reduces clearance and is a predisposing factor for angular cheilitis. 
 
Drug therapy 
Broad-spectrum antimicrobial therapy alters the oral microbiota (Cannon & Chaffin, 
1999a). This dysbiosis promotes the proliferation and growth of Candida. Excessive use 
of antimicrobial mouthwash may induce resistance in C. albicans strain (Edlind, Smith, 
& Edlind, 2005). Aerosolised corticosteroids (as in steroid inhalers), as well as topical 
and systemic corticosteroids, cause local immunosuppression making the host tissue 
susceptible to Candida invasion (Kennedy et al., 2000).  
 
Hyposalivation 
Xerostomia, which is the sensation of dry mouth, may be caused by hyposalivation or 
altered taste sensation. Hyposalivation (salivary gland hypofunction) is the production of 
less than 2 ml per min of unstimulated whole saliva (Longman et al., 1997). Patients with 
hyposalivation have an increased rate of oral mucosal candidiasis symptoms and higher 
Candida carriage compared to controls (Shinozaki et al., 2012), with colony counts of 
more than 400 cfu/ml (Nadig et al., 2017). Saliva in the oral cavity is useful for 
lubrication, buffering action, clearance, maintenance of tooth and mucosal integrity, 
antibacterial and antifungal activity, taste and digestion (Humphrey & Williamson, 
2001). Hyposalivation may be due to many factors including physical damage to salivary 
glands such as trauma or surgery. Radiotherapy often used as primary therapy in head 
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and neck cancer or as an adjunct to surgery or combined with chemotherapy can 
contribute to hyposalivation (Mercadante, Al Hamad, Lodi, Porter, & Fedele, 2017). 
Radiation causes an acute inflammatory reaction followed by fibrosis of salivary glands, 
reduced blood flow and loss of acinar cells resulting in decreased salivary flow. 
Radiation-induced salivary gland dysfunction is dependent on the radiation dose (more 
than 26G) and field (Hegarty & Hodgson, 2008). Another main cause of hyposalivation 
is xerogenic medication, such as anticholinergic drugs, antihistamines, sedatives, 
hypnotics, and beta-blockers, especially when taken concurrently (Hegarty & Hodgson, 
2008). Diseases can affect salivary gland function and reduce salivary flow, for example, 
sialadenitis due to Sjogren’s syndrome, hepatitis C and HIV infection and sialadenosis 
in cases of diabetes mellitus, alcoholism and eating disorders (Farah, Lynch, & 
McCullough, 2010). 
 
Dietary Factors 
Candida can utilise glucose, sucrose, galactose, fructose, and mannose for growth and 
proliferation. Diets rich in glucose and galactose improve Candida biofilm formation on 
acrylic denture surfaces (Nikawa, Nishimura, Hamada, Kumagai, & Samaranayake, 
1997). The presence of high glucose concentrations in the oral cavity is a contributing 
factor to increasing Candida load. Nutritional deficiency in iron, folate, vitamin B₁₂, and 
vitamin C reduces host defences and results in the loss of mucosal integrity 
(Bhattacharya, Misra, & Hussain, 2016). This condition increases the host’s vulnerability 
to invasion of tissues by Candida.  
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Malignant Disease 
Haematologic malignant disease such as leukaemia, lymphoma and myeloma alter the 
production and function of white blood cells debilitating the host immune system. 
Patients with these malignant conditions as well as other types of cancer usually undergo 
cytotoxic chemotherapy or radiotherapy or a combination of both. These treatment 
modalities impair the host immune system by reducing the number of innate immune 
cells and components of the adaptive immune system, putting the patient at risk of 
infection (Teoh & Pavelka, 2016). Cancer therapies reduce cell proliferation and turnover 
in connective tissue. Radiation initially causes inflammation of the mucosal tissue, 
followed by fibrosis, hypo-vascularity and tissue ischaemia which reduce the ability of 
the tissue to heal and resist Candida infection (Squier & Kremer, 2001).   
 
Endocrine Disorders 
Patients with endocrine disorders may present with immune cell deficiency, where 
surveillance for recognition and destruction of Candida cells is inefficient, increasing the 
risk of infection. Patients with diabetes show a neutrophil defect and impaired phagocytic 
activity of lymphocytes and monocytes (Lecube, Pachón, Petriz, Hernández, & Simó, 
2011) making them more susceptible to Candida infection. Lack of insulin or blocked 
insulin action prevents glucose from entering cells and it accumulates in tissues, blood, 
and urine instead. Glucose is utilised by Candida for growth, adhesion, biofilm formation 
and antifungal resistance (Rodaki et al., 2009). Patients with Addison’s Disease 
(adrenocortical hypofunction) will be on long term corticosteroid therapy to replace 
missing hormones. As steroids suppress the immune system, there is increased 
susceptibility to infections. Hypothyroidism on its own, or as part of Autoimmune 
 34 
Polyendocrinopathy Type 1 (APECED) syndrome, may present with persistent 
candidiasis (Humbert et al., 2018). 
 
Immunodeficiencies 
Over 60% of HIV-infected patients, and more than 80% of patients diagnosed with AIDS 
present with pseudomembranous candidiasis and erythematous candidiasis (Farah et al., 
2010). Patients with severe immunodeficiency syndromes, for example, DiGeorge 
syndrome, hereditary myeloperoxidase deficiency and Chediak-Higashi syndrome often 
present with candidiasis(Farah et al., 2010). Patients on long-term steroid therapy for the 
management of asthma, connective tissue disorders (e.g. rheumatoid arthritis, systemic 
lupus erythematosus), gastrointestinal disorders (e.g. ulcerative colitis, Chron’s disease), 
mucocutaneous disease (pemphigus), post organ transplant or renal disorders (nephrotic 
syndrome) are immunosuppressed and at higher risk of Candida infection. 
 
1.2.4.2 Clinical manifestations of Candida infection of the mouth: 
Pseudomembranous Candidiasis 
This is the most common type of candidiasis and it occurs on the soft palate, oropharynx, 
buccal mucosa, tongue and gingiva (Niimi, Firth & Cannon 2010). It presents as non-
adherent creamy or yellow plaques which are easily removed exposing an erythematous 
base which bleeds easily. Patients may experience pain, burning sensation, altered (sour) 
taste sensation, and bleeding. This condition may be acute (recent onset, not more than 3 
months) or chronic (lesion present for more than 3 months). Chronic pseudomembranous 
candidiasis is commonly seen in immunocompromised patients for example patients 
undergoing chemotherapy, poorly controlled diabetes, leukaemia, and HIV/AIDS 
(Williams & Lewis, 2011).  
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Erythematous Candidiasis 
Erythematous candidiasis presents as a well-demarcated erythematous area, or 
depapillated area of the tongue. The acute type is associated with antibiotic and/or 
corticosteroid use (Williams & Lewis, 2011). Chronic erythematous candidiasis, also 
known as denture-induced stomatitis, usually presents as an erythematous region of the 
fitting surface of a denture (Zegarelli, 1993). The Newton (1962) classification of this 
condition is as follows: 
Type I Localised inflammation  
Type II Diffused erythema involving part of, or entire, denture-bearing area 
Type III Inflammation, erythema and granular or papillary type of tissue 
hyperplasia 
This is commonly seen in patients with poor denture hygiene who routinely leave their 
dentures in their mouth overnight.  
 
Plaque-like/nodular Candidiasis 
This type of presentation is also known as chronic hyperplastic candidiasis. It mainly 
presents as chronic, irregular, well-demarcated, slightly raised, adherent white plaques. 
It may be homogenous or speckled and usually found in the post-commissural buccal 
mucosa. This is a potentially malignant lesion, with malignant transformation seen in up 
to 60% of cases (Bakri, Hussaini, Holmes, Cannon, & Rich, 2010). Some lesions of this 
nature do resolve with antifungal therapy. Close monitoring is necessary for persistent 
lesions due to its propensity to undergo malignant transformation. 
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Angular cheilitis 
This type of candidiasis presents as inflamed, crusting and cracking of the commissure 
at the corners of the mouth. This may be caused by local factors like reduced facial height 
and poor muscle tone. Systemically, it may be due to vitamin or mineral deficiency (iron, 
folate, vitamin B₁₂) as seen in patients with anaemia (Coronado-Castellote & Jiménez-
Soriano, 2013). There is commonly a bacterial component (for example Staphylococcus 
aureus) associated with this lesion (Zegarelli, 1993). Treatment for this type of 
candidiasis is the management of the underlying cause and use of topical antifungals and 
antibiotics. 
 
Median Rhomboid Glossitis  
This is a symmetrical, depapillated, erythematous, rhombus/diamond/elliptical-shaped 
lesion on the posterior dorsal surface of the tongue anterior to the circumvallate papilla. 
This is due to atrophy of filiform papilla in the area and is a form of chronic fungal 
infection. It is usually asymptomatic, however some patients experience a burning 
sensation on taking certain types of food (Radfar, 2015). 
 
Chronic Mucocutaneous Candidiasis 
This condition presents as recurrent and progressive Candida infections of the skin, nails, 
oral cavity and genital mucosa. It is associated with defects in acquired cellular 
immunity, with T-cell and Th17 deficiency. The disease may be associated with 
endocrine and autoimmune disorders of hereditary origin, for example APECED 
syndrome (Humbert et al., 2018).  Infections are usually superficial, and systemic 
candidiasis is rarely observed. The treatment consists of management of the underlying 
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cause - therapy for the infectious disease, endocrinopathies and specific treatment for the 
immunological deficiency.  
 
1.2.4.3 Diagnosis of Candidiasis 
A diagnosis of candidiasis is made mainly from the clinical and medical history as well 
as an oral examination of presenting signs and symptoms. The clinical diagnosis may be 
confirmed with microbiological and/or cytological or histological investigation. 
Microbiological investigations may be carried out to establish a differential diagnosis 
and to determine possible resistance to antifungal drugs. The diagnosis of candidiasis can 
be confirmed cytologically by confirming the presence of hyphae in mucosal smears or 
histologically with biopsies stained with Haematoxylin and Eosin (H&E), Grocott-
Gomori's Stain (GMS) or Periodic acid–Schiff (PAS) (Guarner & Brandt, 2011). C. 
glabrata, which can cause candidiasis, is unable to form hyphae or pseudo-hyphae and 
so is not identified morphologically.  
 
Candida species may be identified using CHROmagar Candida or Chromagar ID, which 
use chromogenic chemicals in the agar to colour growing yeast colonies. These agars can 
be used to isolate and differentiate certain Candida species and quantify the presence of 
yeast by counting colony forming units (cfus). Candida species are presumptively 
identified according to the colony colour. This diagnostic method is easily accessible and 
simple to use (Coronado-Castellote & Jiménez-Soriano, 2013). The yeast species and 
strain can be confirmed with DNA sequencing techniques like Multi Locus Sequence 
Typing (MLST) as used in this study. The internal regions of seven selected 
housekeeping genes are sequenced to identify inter-strain genetic relatedness. This 
method is highly discriminatory and reproducible for the characterization of C. albicans 
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(Bougnoux, Morand, & d’Enfert, 2002)(Bougnoux et al., 2003)(Muñoz, Wintaco, 
Muñoz, & Ramírez, 2019). Other yeast species may be identified through sequencing the 
internal transcribed space (ITS) regions ITS1 and ITS2 of the small subunit rRNA 
(Hoggard et al., 2018). Candida carriage can be investigated by plating a known volume 
of an oral rinse or whole saliva on Sabouraud dextrose agar. Patients with clinical signs 
of Candida infection had been found to have greater than 400 cfu per ml of saliva, 
compared to carriers of C. albicans that had less than 400 cfu per ml saliva (Epstein, 
Pearsall, & Truelove, 1980). Fluorescent in situ hybridization (FISH) can be used to 
detect yeast in blood samples (Guarner & Brandt, 2011) and multiplex tandem PCR has 
the potential for earlier diagnosis of candidemia from serum and plasma samples (Lau et 
al., 2010).  
 
It is important to determine the underlying cause of the disease, as candidiasis rarely 
occurs without predisposing factors. Poor denture retention, stability, hygiene, and low 
vertical dimension may be contributing factors. Patients with angular cheilitis may 
require a full blood count, and measurement of iron and folate levels. Patients with 
chronic mucocutaneous candidiasis, HIV-positive individuals and others with systemic 
disease will require blood tests for haematological and immunological investigation. 
Hyposalivation affects buffering in the oral cavity and reduces the clearance of Candida. 
An unstimulated saliva flow test may be conducted to detect hyposalivation, 0.3 ml/min 
is the normal flow rate, level of less than 0.2 ml/min is regarded as salivary hypofunction 
(Longman et al., 1997) while values below 0.1 ml/min are considered extremely low 
(Humphrey & Williamson, 2001).  
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Candida infections may have similar clinical presentations to other oral conditions. For 
example, traumatic lesions, chemical burns, lichen planus, mucositis, erythema 
multiforme, systemic lupus erythematosus, and syphilis may all have intra-oral 
appearances that mimic Candida infection (Farah et al., 2010)(Millsop & Fazel, 2016). 
Therefore, it is extremely important that clinicians make the correct diagnosis in order 
to provide appropriate treatment.  
 
 
 
1.2.4.3 Treatment of candidiasis 
 
Treating the underlying cause is the best long-term management strategy in dealing with 
candidiasis. This will address the root cause and minimise the use of antifungal drugs. 
  
Patients who have been taking long-term antibiotics may experience a reduction in 
candidiasis with the cessation of antibiotics. The cessation of antibiotics allows re-growth 
of oral bacteria, restoring natural microbial balance (Cannon & Chaffin, 1999). 
Candidiasis caused by the use of steroid inhalers due to effect of the immunosuppressant 
agent on the mucosa may be controlled by the use of a spacer for inhaled corticosteroid 
delivery (Pramod & Jayasree, 2013). 
 
Chronic erythematous candidiasis can be managed by addressing the condition of the 
patient’s dentures. Denture hygiene should be evaluated and improved by daily cleansing 
and soaking the dentures twice a week for about half an hour in white vinegar (diluted 
1:20), 0.1% hypochlorite solution, or chlorhexidine gluconate (2% suspension), and then 
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rinsing them and allowing them to air dry  (Farah et al., 2010)(Millsop & Fazel, 2016). 
Dentures should not be worn overnight to encourage salivary flow to cleanse the denture 
fitting surface.  
 
Angular cheilitis caused by a lowered facial height may be corrected by increasing the 
patient’s vertical dimension. This may be done by rebasing or remaking the dentures to 
the correct height or increasing the height of posterior teeth in cases of attrition. Patients 
suffering from iron and or vitamin B deficiency, need to be investigated to determine the 
cause of the deficiency.  
 
Minimising the availability of sugars in the oral cavity slows down the proliferation of 
Candida. This can be achieved by reducing the intake of sugary foods and beverages. 
Effective removal of oral sugars must be carried out by brushing teeth, gums, and tongue 
twice a day as well as interdental cleaning by using floss or interdental brushes.  
 
Hyposalivation can be managed by stimulation and substitution. Saliva flow may be 
stimulated by: 
1)    Taking sugar-free chewing gum and sweets, mechanical oral stimulation encourages 
saliva production (Gavião & Bilt, 2004)(Matsuda, Ikebe, Ogawa, Kagawa, & Maeda, 
2009). 
2)    Salivary gland massage, repeated direct stimulation through the feedback system 
increases salivary flow (Ono & Uchiyama, 2017).  
3)    Using a cholinergic agonist such as pilocarpine which is a direct acting cholinergic 
parasympathomimetic agent. It stimulates muscarinic receptors in secretory glands 
(Mercadante et al., 2017). 
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Adverse reactions to pilocarpine are nausea, dyspepsia, hypertension, palpitation, 
headache, visual disturbances, pruritus, and urinary urgency. It provides an additive 
action when used with other cholinergic and anticholinesterase drugs (e.g. donepezil, 
galantamine, rivastigmine). There is the risk of bradycardia when used with beta blockers 
(such as atenolol, bisoprolol, metoprolol). The recommended dose for pilocarpine 
hydrochloride 4% is 5 mg 3-4 times a day (up to 30 mg per day), swish in mouth and 
swallow. 
 
 
Saliva substitutes may be used such as: 
1)    Methylcellulose (1%): 1-2 sprays at the back of the mouth and tongue as required 
2)    Oralube: 1-2 sprays at the back of mouth and tongue as required. 
3)    GC Dry Mouth Gel: Apply gel on the tongue and spread on oral mucosa as needed. 
         
Oral candidiasis may be treated with antifungal agents either topically or systemically 
depending on the severity of the infection. Antifungals may be divided into five classes: 
polyenes, azoles, echinocandins, allylamines, and other agents, according to the 
mechanism of action. 
 
Polyene antifungal agents such as nystatin and amphotericin B bind to ergosterol 
molecules in the plasma membrane of Candida cells. This forms aqueous pores which 
alter the membrane permeability, resulting in leakage of intracellular ions and cell death 
(Ghannoum & Rice, 1999). Polyenes interact to some degree with cholesterol-containing 
membranes, making it relatively toxic to host cells (Perfect, 2017). Nephrotoxicity is one 
of the main side effects of amphotericin B. Newer lipid formulations of this drug have 
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been developed to reduce renal dysfunction. These drugs are not absorbed when taken 
orally. They may be used topically for oral, oropharyngeal and perioral lesions, otherwise 
they are given intravenously for systemic fungal infection (The New Zealand Formulary, 
2019). 
 
Azole antifungal agents inhibit the fungal cytochrome P450 enzyme lanosterol 14α-
demethylase which reduces the ergosterol content of membranes, and thus inhibits 
growth and replication (Chen & Sorrell, 2007). First generation azoles possess imidazole 
rings (containing 2 nitrogen atoms) and include clotrimazole, miconazole, and 
ketoconazole. Second generation azoles possess triazole rings (containing 3 nitrogen 
atoms) and include fluconazole and itraconazole. Third generation triazoles include 
voriconazole and posaconazole. Newer azoles have improved antifungal activity, safety, 
pharmacokinetics, and formulations; however, they still inhibit mammalian cytochrome 
P450 enzyme, allowing multiple drug interactions (Perfect, 2017). Hepatotoxicity, drug 
interactions, interference with QT (heart beat) interval and peripheral neuropathy are 
adverse reactions associated with azole drugs (Mourad & Perfect, 2018). 
 
Echinocandin antifungals such as caspofungin and micafungin block 1,3-β-glucan 
synthase, preventing cell wall synthesis. This is highly specific to the fungal cell wall; 
echinocandins are less toxic to host tissues which do not have cell walls.  Caspofungin is 
active against Aspergillus and Candida species while micafungin is indicated for azole-
resistant fungal infections (The New Zealand Formulary, 2019). Infusion-related adverse 
reactions have been noted due to histamine release causing symptoms such as rash, 
hypotension, bronchospasm, and angioedema (Mourad & Perfect, 2018). Hepatotoxicity 
has been reported with micafungin use (The New Zealand Formulary, 2019) . 
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Echinocandin drugs are only available for intravenous transfusion and are used for 
invasive candidiasis and candidemia (Perfect, 2017). 
 
Allylamine antifungal agents inhibit early steps of ergosterol biosynthesis and increase 
membrane permeability resulting in disruption of the cellular function of Candida 
(Ghannoum & Rice, 1999). Terbinafine has shown good inhibition of C. albicans, azole-
resistant Candida and Cryptococcus neoformans (Ghannoum & Rice, 1999) (The New 
Zealand Formulary, 2019).  
 
Flucytosine interferes with pyrimidine metabolism, RNA, DNA, and protein synthesis in 
the fungal cell (Ghannoum & Rice, 1999). It is used in combination with a polyene for 
cryptococcal meningitis and severe systemic candidiasis. Flucytosine is not used as 
monotherapy due to the rapid development of fungal drug resistance (Mourad & Perfect, 
2018). Leukopenia, thrombocytopenia, and hepatotoxicity have been reported with this 
drug use (The New Zealand Formulary, 2019). 
 
1.3 Clinical relevance 
 
Understanding the distribution of yeast species and strains among the older population is 
important in implementing strategies for disease prevention. As the proportion of older 
people in the population increases, the focus should be aimed towards improving oral 
health care. This is because older people are living longer with multiple medical 
comorbidities and risks for oral candidiasis. Prevention of oral diseases leads to better 
overall health and quality of life.  
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1.4 Objective of this study: 
To investigate and compare the prevalence of Candida species and C. albicans strains in 
the oral cavities of older people living in institutional age-care facilities and those living 
at home. 
 
1.5 Aims of the investigation: 
To investigate the presence and abundance of Candida species in saliva and from swabs 
and smears of people living at an institutional rest home and those living at home. 
To detect and identify different types of C. albicans strains using Multi Locus Sequence 
Typing (MLST) in the two population groups. 
 
1.6 Hypothesis 
There are significant differences in the prevalence of Candida species and C. albicans 
strains between older people living in an institutional care facility and those living at 
home.  
 
1.7 Significance of this research 
Upon completion of this study, we will have a better understanding of the prevalent 
Candida species and strains in the mouths of older people. We will also be able to 
determine if communal living, for example living in close proximity to one another, 
sharing the same caregivers and food handlers for those who reside in age-care facilities 
has an impact on this prevalence. A review of oral hygiene and cross-contamination 
protocols may be needed to improve the overall healthcare of the elderly. 
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Chapter 2: Materials and Methods 
 
2.1 Materials 
 
2.1.1 List of Materials  
i) Agarose gel 1.5% 
Preparation: 
2.1 g agarose powder UltraPure™ (ThermoFisher Scientific, Christchurch New Zealand) 
140 ml Tris Acetate EDTA(TAE) Buffer (40 mM Tris, 20 mM acetic acid, 1 mM EDTA, 
pH 8.3) 
0.5 µl Ethidium Bromide (EtBr 2 mg/ml) 
Put room temperature buffer (TAE) into a 500ml flask. Place a magnetic stir bar into the 
flask. Place the flask on a magnetic stirrer and add the agarose powder as the solution 
mixes, to prevent the formation of agarose clumps. Remove the stir bar. Cover the flask 
opening with plastic wrap, pierce a small hole for ventilation. Place the flask in the 
microwave oven and heat until bubbles appear. Remove the flask carefully and swirl 
gently to resuspend any agarose particles. Reheat the solution until it comes to a boil, and 
all the agarose particles are dissolved. Remove the flask carefully and swirl gently to 
fully mix the solution. Place the flask under running water while gently swirling the 
contents and let cool to 50–60°C. Add EtBr and swirl to get an even mix before pouring 
the solution into 2 large casting trays. Ethidium Bromide is a fluorescent intercalating 
agent that binds to DNA, allowing DNA visualization under UV light. It is a potentially 
mutagenic compound and should be handled according to the material safety data sheet. 
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ii) CHROMagar™ Candida agar plates (Becton Dickinson & Co [BD], Franklin Lakes, 
NJ, USA) 
Supplier: Fort Richards Ltd, Auckland, New Zealand 
 
iii) ExoSAP-IT™ (ThermoFisher Scientific) 
Supplier: Life Technologies NZ Ltd, Christchurch, New Zealand 
 
iv) KOD FX Neo DNA Polymerase (Toyobo, Osaka, Japan) 
Supplier: Biotech Lab Inc, Tokyo, Japan 
 
v) Yeast extract Peptone Dextrose (YPD) Agar 
Preparation: 
10 g yeast extract 
20 g peptone Sigma-Aldrich (St. Louis, MO, USA)   
20 g glucose 
20 g agar 
700 ml distilled water  
Place water with magnetic stir bar into a beaker onto a magnetic stirrer and begin stirring 
at medium speed. Add yeast extract, peptone and glucose until all powders have 
dissolved. Add agar when other ingredients are dissolved. Remove the stir bar and pour 
solution into a graduated cylinder and add distilled water to make 1 liter. Place solution 
into screw cap glass bottle. Autoclave at 121˚C for 20 minutes. Place in water bath at 
46˚C for one hour then pour into sterile, labeled petri dishes. Allow to cool and set.  
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vi) Yeast extract Peptone Dextrose (YPD) liquid medium 
Preparation:  
5 g yeast extract, 
10 g glucose, 
10 g peptone Sigma-Aldrich  
Distilled water  
Mix all the above ingredients with distilled water to make 500 ml in a beaker with a 
magnetic stir bar. Place on a magnetic stirrer and mix well. Pipet 10 ml portions of the 
medium into glass universal bottles, cover and autoclave at 121˚C for 15 min. 
 
vii) Yeast extract Peptone Dextrose (YPD) glycerol medium  
Preparation:  
5 g yeast extract, 
10 g glucose, 
10 g peptone Sigma-Aldrich   
125 g glycerol 
Distilled water 
Mix all the above ingredients with distilled water to make 500 ml in a beaker with a 
magnetic stir bar. Place on a magnetic stirrer and mix well. Pipet 10 ml portions of the 
medium into glass universal bottles, cover and autoclave at 121˚C for 15 min. 
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2.2 Methods 
 
2.2.1 Study Participants 
2.2.1.1 Ethical Approval 
Ethical approval for this study was obtained from the University of Otago Human Ethics 
Committee (Ethics Committee reference number H17/081) prior to recruitment of 
participants. Consultation was undertaken with the Ngāi Tahu Research Consultation 
Committee. 
 
2.2.1.2 Participant Selection 
This pilot cross-sectional study was a convenience sampling of two groups of older 
people; people living at rest home facilities (n = 25) and people living in their own homes 
(n = 25). The term “Rest Home” is unique to New Zealand and is the name for a long-
term residential nursing facility or nursing home. These facilities cater for older people 
with varying levels of dependency. Rest home participants came from Montecillo 
Veterans Home and Hospital and Little Sisters of the Poor, both located in Dunedin, New 
Zealand. Participants for the control group were members of the community recruited 
using posters circulated via Age Concern, Bowling Clubs Dunedin and by personal 
contact. 
  
2.2.1.3 Inclusion criteria 
Participants had to be aged 65 or older and healthy (no sign of disease), or have well-
controlled systemic disease, with sufficient mouth opening to allow intraoral access and 
possess the ability to consent to participate. 
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2.2.1.4 Exclusion criteria 
Individuals who had used antibiotics or antifungals in the past two months or were 
terminally ill or current tobacco smokers were excluded from participating in the study. 
 
The selection criteria were provided to the rest homes and names of suitable candidates 
were supplied by the Nurse Manager. Participants were given the information sheet 
(Appendix III) and had ample opportunity to ask questions and voice any concerns. 
Consent forms (Appendix IV and V) were signed, or verbal consent was given by patients 
with physical disability. This process was carried out at the participant’s bedside (rest 
home) or in their own home (control). 
 
2.2.2 Sample Collection and Analysis 
 
2.2.2.1 Clinical examination 
A clinical examination was carried out by the researcher, involving direct observation of 
the condition of the oral mucosa using cheek retractors a dental mirror. Participants who 
exhibited signs of mucosal inflammation and had hyphae present in the smear test were 
prescribed antifungal agents. This was either miconazole nitrate oral gel 2% (applied to 
affected site and placed on fitting surface of denture 4 times a day for 2 weeks) or 
amphotericin B 10g lozenges (1 lozenge dissolved in mouth 4 times a day for 2 weeks) 
or both. Denture wearers were advised to remove dentures overnight and denture hygiene 
instructions were given. The rest home in-house medical doctor and the nurse manager 
were involved in this process to provide participant support. Participants who required 
urgent dental attention were referred to the Urgent Care Unit of the Faculty of Dentistry, 
University of Otago, for immediate treatment. 
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2.2.2.2 Collection of oral samples 
Whole saliva 
Whole unstimulated saliva was collected from participants and the rate of production 
measured in order to identify salivary gland hypofunction (a rate of  <0.2ml/min 
(Longman et al., 1997)). Participants were requested to allow their saliva to pool in their 
mouths for one minute then expectorate it into a glass measuring cup. This was repeated 
five times. The total volume of saliva produced was recorded and the saliva transferred 
to a sterile 15 ml Falcon tube. Patients who were unable to generate saliva rinsed their 
mouths with 2 ml sterile water to enable subsequent analysis of the yeast present in their 
mouths. 
 
Mucosal Swabs 
Participants’ hard palates and dorsal surface of tongues were swabbed with sterile cotton 
buds, then the cotton buds were placed in 2 ml sterile water contained in a 15 ml Falcon 
tube. Saliva and mucosal swabs were kept on ice and transported to the Faculty of 
Dentistry Molecular Biosciences Laboratory for further analysis. 
 
Mucosal Smears 
Smears of the palate and tongue were taken by gently rubbing a wooden spatula on the 
dorsal surface of the tongue and hard palate, avoiding the area that had just been swabbed, 
but immediately adjacent to it. The material obtained on the spatula was smeared onto a 
glass slide and the slide immersed in a Coplin jar filled with 95% ethanol. Glass slides 
were labeled with the participant’s name, date of birth and site from which the smear was 
taken. The Coplin jars were transported to the University of Otago Faculty of Dentistry 
Oral Pathology Centre where they were stained with Periodic acid-Schiff (PAS). PAS 
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detects glycogen in fungal walls which stains pink to red/purple and is well differentiated 
from host tissues (Guarner & Brandt, 2011). 
 
2.2.2.3 Cytology 
PAS-stained slides were examined by an Oral Pathology Consultant to determine the 
presence or absence of hyphae and/or yeast.  
 
2.2.3 Laboratory Procedures 
 
2.2.3.1 Yeast identification, quantification and storage 
Falcon tubes containing saliva and the 2 ml suspensions of palate and tongue swabs were 
vortexed for 30s. Portions (100 µl) of the whole saliva and suspensions were spread on 
CHROMagar™ Candida agar plates (Becton Dickinson & Co [BD], Franklin Lakes, NJ, 
USA), and incubated at 37˚C for 48 h. CHROMagar™ Candida agar contains 
chromogenic b-glucosaminidase substrates that report yeast hexosaminidase and alkaline 
phosphatase activity. The reaction of these substrates with species-specific enzymes 
gives colonies different colours: green (C. albicans), purple (C. glabrata), pink (C. 
krusei) and white (C. parapsilosis) (Ghelardi et al., 2008). Candida species were 
presumptively identified according to colony colour based on the manufacturer’s 
instructions, and colony forming units (cfu) per ml sample were determined. The number 
of colonies on plates were multiplied by 10 to get the cfu/ml sample. When the numbers 
of cfu were too high to count accurately, portions of saliva and swab suspensions were 
serially diluted 10, 100 or 1000 times and the number of cfu multiplied accordingly in 
order to accurately quantify the cfu per 1 ml sample. Five colonies presumptively 
identified as C. albicans were picked from each site (saliva, tongue and palate) with a 
 52 
sterile loop, and the cells were suspended into 10 ml sterile Yeast Extract–Peptone–
Dextrose (YPD) liquid medium. From sites that had other yeast species present, three 
additional colonies of each species were picked. The cell suspensions were incubated by 
shaking (200 rpm) overnight at 30˚C in a rotary incubator (Multitron II Infors HT, 
Bottmingen Switzerland). Cells were harvested by centrifugation at 5000 rpm (3184 x g) 
for 3 min using a Centrifuge 5804 Eppendorf Darmstadt, Germany. Cells were then 
resuspended in 1 ml sterile YPD containing 25% (w/v) glycerol as a cryo-protectant. 
After allowing glycerol to diffuse into the cells for ~30 min the cell suspension was 
transferred into screw capped 1.5 ml Eppendorf tubes and stored at -80˚C.  
 
2.2.3.2 DNA analysis 
Polymerase Chain Reaction amplification 
Yeast species were confirmed by colony polymerase chain reaction (PCR) amplification 
and sequencing of the rDNA internal transcribed spacer region ITS2 (Hoggard et al., 
2018) (Lott, Kuykendall, & Reiss, 1993). Colony PCR was carried out using KOD FX 
Neo DNA Polymerase (Toyobo, Osaka, Japan) and dNTP. Each 20 µl PCR reaction 
contained: 
0.8 µl sterile water; 
10 µl 2 x PCR Buffer for KOD FX Neo; 
4 µl dNTPs (2 mM); 
2 µl ITS3 forward primer: (Table 1) (3.2 µM); 
2 µl ITS4 reverse primer (Table 1) (3.2 µM); 
1 µl of template cell suspensions in 20 µl sterile water of each yeast colony; and 
0.2 µl KOD FX Neo (1.0 U/µl).  
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Table 1. ITS primers used for yeast identification 
Primer Primer sequence 
rRNA operon binding 
site 
ITS 3 (forward) 5’-GCATCGATGAAGAACGCAGC-3’ 5.8S 
ITS 4 (reverse) 5’-TCCTCCGCTTATTGATATGC-3’ Large subunit 
(Op De Beeck et al, 2014) 
 
The PCR cycle conditions were:  
1) Initial denaturation at 98°C for 30 seconds  
2) Denaturation at 98°C for 10 seconds  
3) Annealing at 55°C for 10 seconds  
4) Elongation at 68°C for 40 seconds (step 2 to 4 were repeated for 44 cycles) 
5) Final elongation step at 68°C for 1 minute 
 
C. albicans strain typing was carried out by PCR amplification of fragments of the seven 
housekeeping genes AAT1a, ACC1, ADP1, MP1b, SYA1, VPS13, and ZWF1b (Table 2) 
(Bougnoux et al., 2003) using the protocol above. 
 
Table 2. Gene fragments and primers used for C. albicans MLST analysis  
Gene Gene Product Primers 
Amplicon size 
(bp) 
    
AAT1a Asparate aminotransferase 
Fwd5′-ACTCAAGCTAGATTTTTGGC-3’ 
Rev 5′-CAGCAACATGATTAGCCC-3′ 
478 
    
ACC1 Acetyl-CoA carboxylase 
Fwd 5’-GCAAGAGAAATTTTAATTCAATG-
3’ Rev 5’-TTCATCAACATCATCCAAGTG-3 
519 
    
ADP1 ATP-dependent permease 
Fwd 5′-GAGCCAAGTATGAATGATTTG-3′ 
Rev 5′-TTGATCAACAAACCCGATAAT- 
537 
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MPIb Mannose phosphate isomerase 
Fwd 5′-ACCAGAAATGGCCATTGC-3′ 
Rev 5′-GCAGCCATGCATTCAATTAT-3′ 
486 
    
SYA1 Alanyl-tRNA synthetase 
Fwd 5′-AGAAGAATTGTTGCTGTTACTG-3′ 
Rev 5′-GTTACCTTTACCACCAGCTTT-3′ 
746 
    
VPS13 Vacuolar protein sorting protein 
Fwd5′-TCGTTGAGAGATAATCGACTT-3′    
Rev 5′-ACGGATGGATCTCCAGTCC-3 
741 
    
ZWF1b 
Glucose-6-phosphate 
dehydrogenase 
Fwd 5′-GTTTCATTTGATCCTGAAGC-3′ 
Rev 5′-GCCATTGATAAGTACCTGGAT-3′ 
702 
    
(Bougnoux et al, 2003) 
 
DNA gel electrophoresis 
The presence of DNA fragments of correct size and their concentrations were determined 
by subjecting 1 µl of the 20 µl PCR amplified DNA sample mixed with 5 µl of 1x 
Bromophenol Blue Loading Dye (3′,3′′,5′,5′′-Tetrabromophenolsulfophthalein sodium 
salt and glycerol) to electrophoresis (100 V for 28 min) through an agarose gel (1.5% 
w/v) containing ethidium bromide (EtBr). EtBr staining was achieved by adding 0.5 µl 
of a 2 mg/ml EtBr stock into 140 ml of 1.5% agarose gel mixture. 
 
PCR product clean up 
Unincorporated DNA oligomer primers were removed from PCR amplified DNA 
fragments with ExoSAP-IT™ (ThermoFisher Scientific, Christchurch, New Zealand) 
according to the manufacturer’s instructions. PCR samples were diluted to give 50ng of 
0.3-0.7kb DNA fragments in 10 µl.  ExoSAP-IT™ (0.1 µl) was added to the PCR sample. 
Samples were incubated at 37˚C for 15 min to remove all unincorporated primers after 
which the temperature was increased to 80˚C for another 15 min to inactivate the enzyme 
that would otherwise interfere with DNA sequencing of the treated samples. 
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DNA sequencing 
DNA sequencing of the PCR amplified internal transcribed spacer region ITS2 was 
carried out to identify yeast species using ITS3 forward primer and performed by the 
Genetic Analysis Service, Department of Anatomy, University of Otago. The 5 µl 
sequence reaction DNA samples that were sent for sequencing ideally contained 1 µl (i.e. 
~5ng-7ng) ExoSAP-ITTM-treated PCR products, 1µl ITS3 forward primer and 3 µl sterile 
distilled water. 
C. albicans strains were typed by sequencing the PCR amplified AAT1a, ACC1, ADP1, 
MP1b, SYA1, VPS13, and ZWF1b gene fragments using the respective forward primers 
(Table 2) and the sequencing protocol described above. 
 
Multi Locus Sequence Typing (MLST) analysis 
Yeast species were confirmed by visualizing the DNA sequencing chromatograms  with 
FinchTV (version 1.5.0) and further analyzed with UniPro UGENE (version 1.29.0) and 
compared with the blast software program to the publicly available nucleotide database 
collection at https://www.ncbi.nlm.nih.gov/BLAST/. (Last accessed 2/8/2019) 
 
The diploid sequence type (DST) of individual C. albicans strains was determined by 
comparing concatenations of the seven housekeeping gene fragment sequences with the 
publicly available MLST database (https://pubmlst.org/calbicans/). Allelic variation was 
determined by the presence of single nucleotide polymorphisms (SNPs) (double peaks) 
in the chromatogram. The allelic variation of C. albicans strains between participants and 
within a participant was recorded. 
The concatenated sequence of all the genes were uploaded to the Phylemon 2.0, an online 
platform for phylogeny and molecular evolution analysis. 
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2.2.3 Statistical analysis 
 
The t-test was used to compare parametrically distributed data. The Mann-Whitney U 
test was used to compare non-parametrically distributed data. Differences were 
considered significant if p < 0.05. For binary dependent variables, SPSS software 
(version 25, IBM Corporation) was used for cross-tabulations, with Chi-square tests used 
to determine statistical significance (at the 0.05 level). 
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Chapter 3: Results 
 
3.1 Overview 
 
This pilot cross-sectional study was a convenience sampling of two groups of older 
people: people living at rest home (RH) facilities (n = 25) and people living in their own 
homes (OH) (n = 25). Enrolling participants from aged care facilities in Dunedin proved 
to be very challenging as many facilities cited over-commitment to various other research 
projects carried out by the University of Otago. The two RHs that agreed to participate 
were Montecillo Veterans Home and Hospital (Montecillo; n=13) and Little Sisters of 
the Poor (LSOP) Sacred Heart Home and Hospital (n=12). The list of eligibility criteria 
(see section 2.2.1.3 and 2.2.1.4) was given to the RH Nurse Managers who identified 
suitable candidates. The RH residents were approached individually and given the 
Participant Information Sheet (Appendix III) and the opportunity to ask questions about 
the study. Residents who were vision impaired had the information sheet read out to 
them. Residents who agreed to participate signed the Consent Form (Appendix IV) as 
well as the Laboratory Form (Appendix V) consenting to the smear results to be used for 
research. Participants in the control group were members of the public recruited from 
posters circulated via Age Concern (26 Bath St, Dunedin, 9016), Bowling Clubs Dunedin 
and personal contact. People who were interested and eligible to participate were visited 
in their OHs. The participants were given ample opportunity to ask questions about the 
study. OH participants were given both Consent and Laboratory forms to sign before the 
study commenced. 
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3.2 Study participants 
 
A total of 25 people from each group (RH and OH) participated in this study. Each group 
consisted of 17 women and 8 men. Tables 3-5 depict the distribution of the various yeast 
species found in saliva, tongue and palate samples from the oral cavities of OH (Table 
3), Montecillo (Table 4) and LSOP (Table 5) participants. The tables also include the 
participants age and whether they were denture wearers or had yeast hyphae detected in 
the oral smear samples. 
Table 3. Distribution of yeast species colonizing of the oral cavities of OH residents 
(empty cells mean no yeast colonies were detected). 
a C = participants living in their own homes; L = participants with low salivary flow rate (<0.2 ml/min; 
top); N = participants with normal salivary flow rate (³0.2 ml/min; bottom). 
b Ca = Candida albicans, Cg = Candida glabrata, Cl = Candida lusitaniae, Cp = Candida parapsilosis, 
Cgm = Candida guilliermondii, Yl = Yarrowia lipolitica, Pf = Pichia fermentans. 
* These participants were excluded from the analysis presented in Table 6.
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Saliva 
cfu (103 / mL) 
Tongue 
cfu (103 / swab) 
Palate 
cfu (103 / swab) 
Cab 
Non-albicansb 
Cab 
Non-albicansb 
Cab 
Non-albicansb 
Cg Cl Cp Cgm Cg Cp Pf Cg Cp Yl 
CL1* 67  ü 74.00 107.00    1.06 1.34   0.14 0.08   
CL2 72   0.21     0.10        
CL3 76 ü ü 2.54  0.01   0.78    0.54    
CL4 86 ü ü 9.16     1.06    1.12   9.12 
CL5 85 ü ü 0.99     0.06        
CL6 92 ü    0.04           
CL7 84 ü     0.06          
CL8 88 ü ü 3.32 1.08  3.76  0.60  0.08 0.06 0.44 0.14 0.02  
CL9 88 ü   0.23     2.20    0.72   
CN1* 66                
CN2 71 ü  0.02             
CN3* 67   0.05             
CN4 83 ü               
CN5 74                
CN6* 75                
CN7 78 ü               
CN8* 72   0.10             
CN9 82   1.02         0.02    
CN10 92                
CN11 85                
CN12 83  ü 0.21             
CN13 81                
CN14 85 ü  5.54     0.48        
CN15 83  ü 0.02    0.01         
CN16 84                
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Table 4. Distribution of yeast species in the oral cavities of participants living in the 
Montecillo RH (empty cells mean no yeast colonies were detected). 
a M = participants living in Montecillo rest home; L = participants with low salivary flow rate (<0.2 ml/min; 
top); N = participants with normal salivary flow rate (³0.2 ml/min; bottom). 
b Ca = Candida albicans, Cg = Candida glabrata, Cd = Candida dubliniensis, Sc = Saccharomyces 
cerevisiae, Ct = Candida tropicalis, Ch = Candida albicans/Candida dubliniensis chimera. 
* These participants were excluded from the analysis presented in Table 6. 
 
Table 5 Distribution of yeast species in the oral cavities of participants living in LSOP 
RH (empty cells mean no yeast colonies were detected). 
a S = participants living in Little Sisters of the Poor rest home; L = participants with low salivary flow rate 
(<0.2 ml/min; top); N = participants with normal salivary flow rate (³0.2 ml/min; bottom). 
b Ca = Candida albicans, Cg = Candida glabrata, Pa = Pichia anomala, Sc = Saccharomyces cerevisiae, 
Ch = Candida albicans/Candida dubliniensis chimera. 
* These participants were excluded from the analysis presented in Table 6. 
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Saliva 
cfu (103 / mL) 
Tongue 
cfu (103 / swab) 
Palate 
cfu (103 / swab) 
Cab 
Non-albicansb 
Cab 
Non-albicansb 
Ca 
Non-albicansb 
Cg Sc Ch Cg Ct Sc Ch Cg Ct Sc Ch 
ML1* 94 ü ü 3.00 1040.00   0.38 16.48    0.20 12.24    
ML2 94 ü  18.00 1.00   2.64   0.28  0.16 0.08    
ML3 74 ü  2.20    2.04         1.12 
ML4* 95   1.50    0.08     0.02     
ML5 75 ü ü  7.45    14.70 0.06    13.78 0.32   
ML6 92                 
MN1 91 ü                
MN2 94 ü     0.59     1.06     0.34 
MN3 94 ü                
MN4 89 ü  0.41    0.02          
MN5 84 ü ü   4.76 0.05    0.50 4.92    0.18 2.44 
MN6 82                 
MN7* 98 ü  1.04    0.62     0.16     
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Saliva 
cfu (103 / mL) 
Tongue 
cfu (103 / swab) 
Palate 
cfu (103 / swab) 
Cab 
Non-albicansb 
Cab 
Non-albicansb 
Cab 
Non-albicansb 
Cg Pa Cg Pa Sc Ch Cg Pa Sc Ch 
SL1 91 ü ü 1.11   0.18          
SL2 82  ü 24.00   2.26     0.96     
SL3* 94 ü ü   2816   8.48     5.90   
SL4 81 ü ü 9.00 3.00   0.90   2.40  0.26   0.28 
SL5 81   0.45   0.02          
SL6* 102 ü  0.12   0.02          
SL7 89 ü  39.00 1.00  0.74 1.38  0.12  0.28 0.14  0.24  
SL8 83 ü ü 3.37 0.67  3.52 0.06    0.14 0.02    
SL9 73   2.31   4.58     0.96     
SN1 91   17.00 36.00  1.32 1.34    0.38 0.62    
SN2 88 ü  472.00   1.90     0.08     
SN3 87 ü ü 1.51   0.98     0.14     
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In order to match the participants from the two groups in terms of gender and age to 
reduce bias in the comparison, 20 participants from each group were selected without 
reference to any other participant characteristics. Participants excluded from the analysis 
presented in Table 6 are marked with asterisks in Tables 3 - 5.  
 
 
Table 6. Demographics, clinical features, and colonization status of 20 participants 
living in their OH compared with 20 RH participants. 
Variable OH 
(n = 20) 
RH 
(n = 20) 
p Value 
Gender    
Female 13 13  
Male 7 7  
Mean age (range) 83.1 (71-92) 86.0 (72-94) 0.50 a  
Proportion with dentures 55% 70% 0.33 b 
Mean salivary flow rate [ml/min] (range) 0.25 (0-0.7) 0.23 (0-0.6) 0.35 a 
Salivary gland hypofunction (<0.2 ml/min) 40% 55% 0.34 b 
Proportion with hyphae in smears (PAS-positive) 30% 35% 0.74 b  
      Denture wearer                                                              67% 86%  
      Low saliva flow rate          67% 71%  
Mean number of medications (range) 5.4 (0-11) 6.6 (1-12) 0.25 a 
Proportion with saliva colonized by yeast 65% 80% 0.29 b 
Proportion with tongue colonized by yeast 35% 80% 0.004 b 
Proportion with palate colonized by yeast 25% 65% 0.01 c  
Level of yeast colonization of saliva (cfu/ml)    
Mean 1,410 32,240 0.01 c 
Median (range) 50 (0-9,160) 2,260 (0-4.72x105)  
Level of yeast colonization of tongue (cfu/swab)    
Mean 271 2,400 0.001 c 
Median (range) 0 (0-2,200) 1,970 (0-14,760)  
Level of yeast colonization of palate (cfu/swab)    
Mean 606 1,150 0.03 c 
Median (range) 0 (0-10,240) 200 (0-14,100)  
a t-test 
b Chi-square test 
c Mann-Whitney U test 
p values in bold are significant (<0.05). 
 
3.2.1 Demographics 
On average, RH participants were 2.9 years older than those living in their OHs, but this 
difference was not statistically significant (t-test = 0.50). The mean age of OH and RH 
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participants was 83.1 (range: 71-92) and 86.0 (range: 72-94) years, respectively. Thirteen 
subjects of each group (65%) were women and 7 (35%) were men.  
 
3.2.2 Denture Use 
The denture use status was recorded because it is a risk factor for candidiasis (C. Farah 
et al., 2010). About half (55%) of OH and 70% of RH participants wore dentures, which 
was not significantly different (chi-square test = 0.33; Tables 6 and 8). However, 
significantly (p = 0.04; chi-square test) more (84%; 21/25) denture wearing participants 
presented with yeast-positive saliva than non-denture wearing participants (53%; 8/15; 
Table 7).  17 of the 25 denture wearers had high yeast colonization levels (> 400 cfu/ml 
saliva (Nadig et al., 2017)), whereas only 5 of the 15 non-denture wearers had high levels 
of yeast (p = 0.03; Table 7). Perhaps somewhat surprisingly, four out of five were from 
LSOP while non-denture wearers in Montecillo and OH generally did not have high yeast 
carriage. 
 
Table 7. Comparison of saliva yeast presence, yeast colonization level and PAS-positive 
smears between denture wearers and non-denture wearers. 
 Denture wearing participants 
Non-denture wearing 
participants 
p value 
a 
Yeast positive saliva 84% 53% 0.04 
Highly colonized (>400cfu/ml) 68% 33% 0.03 
PAS-positive smear 40% 20% 0.19 
a Chi-square test 
p values in bold are significant (<0.05) 
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Table 8. Distribution of PAS-positive smears and high, low or no yeast cell counts in 
saliva samples of denture versus non-denture wearers with either low (L) or normal (N) 
salivary flow rates. 
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OH (n = 20) 
RH (n = 20) 
Montecillo (n = 10) LSOP (n = 10) 
№ PAS 
Yeast cells count 
№ PAS 
Yeast cell count 
№ PAS 
Yeast cell count 
Higha Lowb No High Low No High Low No 
ü L  7  4 4 3 0 3 1 3 0 0 4  3 4 0 0 
N  4  0 1 1 2 5 1 3 0 2 2  1 2 0 0 
No L  1  0 0 1 0 1 0 0 0 1 3  1 3 0 0 
N  8 2 1 2 5 1 0 0 0 1 1  0 1 0 0 
Total 20  6 6 7 7 10 2 6 0 4 10  5 10 0 0 
a >400 cfu/ml 
b 30-230 cfu/ml 
 
3.2.3 Hyposalivation 
Salivary gland hypofunction (defined as an unstimulated whole salivary flow rate < 0.2 
ml/min) (Longman et al., 1997) was present in 55% of RH participants (Table 6 and 8). 
This was also seen in 40% participants living in their OH. This difference was not 
statistically significant (p = 0.34; chi-square test; Table 6). A greater proportion of 
participants with low salivary flow presented with yeast colonisation compared to people 
with normal salivary flow (95% vs 52% p = 0.002) (Table 9). A greater proportion of 
participants with low salivary flow were highly colonized with yeast and present with 
more PAS-positive smears compared to those with normal salivary flow, but the 
differences were not statistically significant (Table 8 and 9).  
 
Table 9. Comparison of saliva yeast presence, yeast colonization level and PAS positive 
smears between participants with low and normal salivary flow. 
 Low salivary flow (<0.2ml/min) 
Normal salivary flow 
(≥0.2ml/min) 
p value a 
Yeast positive saliva 95% 52% 0.002 
Highly colonized (>400cfu/ml) 68% 38% 0.06 
PAS-positive smear 47% 19% 0.06 
a Chi-square test 
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3.2.4 Cytology Examination 
Six (30%) OH participants were PAS-positive, with hyphae detected in smears taken 
from their palate and/or tongue. Four of them (67%) were denture wearers and had low 
salivary flow. Seven (35%) participants living in RHs had PAS-positive smears. Six of 
them (86%) were denture wearers and five (71%) had low salivary flow (Table 6). 
 
3.2.5 Medication 
Many participants in both cohorts were taking a number of medications. Participants 
living in their OHs were taking between 0 and 11 medications daily with a mean of 5.4.  
RH participants were taking between 1 and 12 medications daily with a mean of 6.6. This 
difference was not statistically significant (p = 0.25; t-test). Participants with low salivary 
flow rate (<0.2 ml/min) were taking a mean of 7.4 medications daily, which was 
significantly more than participants with normal salivary flow rate (4.8 medications 
daily, p = 0.005; t-test). 
 
3.3 Microbiological Analysis 
 
3.3.1 Yeast Colonisation 
 
Yeast colonies were presumptively identified based on their colour on CHROMagar™ 
Candida agar plates. Saliva was the oral site most frequently colonised with yeast, 
followed by the tongue and the least colonised site was the palate (Figure 1). A higher 
proportion of RH residents carried yeast in their oral cavity (80% saliva, 80% tongue, 
and 65% palate) compared to people living at home (65% saliva, 35% tongue, and 25% 
palate). This difference was significant for the tongue and palate colonisation: saliva.  
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Figure 1 Percentage of participants colonised by yeast at each oral site. 
  
Comparing results for the 20 matched OH and RH participants, saliva of participants 
positive for yeast living in RHs had a higher (40,305 cfu/ml) mean yeast carriage (range: 
410-472,000 cfu/ml; Tables 4 and 5) than OH participants (2,171 cfu/ml; range: 20-9,160 
cfu/ml; Table 3). However, 7 OH and 3 RH participants, of which all but one (ML6; 
Table 4) had normal saliva flow, had no detectable yeast in their saliva. Including these 
participants in the calculations reduced their mean yeast saliva levels to 32,240 cfu/ml 
(median: 2260 cfu/ml) and 1,410 cfu/ml (median: 50 cfu/ml), respectively. Participants 
in the two rest homes showed different levels of Candida carriage. LSOP participants’ 
saliva contained, on average, a significantly higher concentration of yeast (61,042 cfu/ml) 
compared to Montecillo participants (3,446 cfu/ml) and this contributed to the increased 
mean yeast concentration for RH participants.  
 
The mean cfu/swab of the tongue samples from OH participants was 271 (range: 0-2,200) 
compared to 2,400 (range: 0-14,760) of the RH participants. The mean cfu/swab of the 
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palate samples from OH participants was 606 (range: 0-10,240) compared to 1,150 
(range: 0-14,100) of the RH participants (Figure 2). Thus, RH participants had 
significantly higher amounts of yeast present in each sample type compared to people 
living in their OH.  
 
 
Figure 2 Quantity of yeast at oral sites in participants. Level of yeast colonization at 
each site in eachgroup (cfu/mL of saliva samples, cfu/swab for tongue and palate swabs 
± standard deviation). 
 
Participants with PAS-positive smears had a higher number of yeast present in their 
mouths, 11 of the 13 PAS-positive participants had more than 400 cfu/ml saliva, 
consistent with previous observations (Epstein et al., 1980). 
 
Most participants with low salivary flow (<0.2 ml/min) (Longman et al., 1997) were 
yeast-positive (18 out of 19 participants, 95%). However, only 11 out of 21 (52%) 
participants with normal salivary flow were yeast-positive (Table 9). Interestingly, most 
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of those 11 participants with normal saliva flow had only C. albicans isolates, only four 
had other yeast species present.  
 
3.3.2 Yeast species distribution colonizing the oral cavity 
C. albicans was the most frequently isolated species by far from the oral cavity from both 
participant groups. Seven yeast species were identified in individuals living in their OH: 
C. albicans, C. glabrata, C. parapsilosis, C. lusitaniae, C. guilliermondii, Pichia 
fermentans and Yarrowia lipolytica (Figure 3). Yeast species identified in individuals 
living in RH were C. albicans, C. glabrata, Saccharomyces cerevisiae, C. dubliniensis, 
C. tropicalis and C. albicans/C. dubliniensis chimera strains.  
 
Figure 3 Species distribution of yeast colonizing the oral cavities of 13 (65%) OH and 
16 (80%) RH participants. 
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From the 120 oral samples taken from both groups of participants, 25 OH and 45 RH 
samples were yeast positive. Of these 70 yeast-positive samples, 44 contained one, 20 
contained two and only six contained three yeast species (Table 10). The majority (68) 
of them contained either C. albicans or C. albicans/C. dubliniensis chimera strains (62) 
or C. glabrata (22). Only two samples (saliva of participants CL6 and CL7) contained 
neither of these three yeast species: saliva of participant CL6 contained a few (40 cfu/ml) 
C. lusitaniae cells and saliva of participant CL7 contained a few (60 cfu/ml) C. 
parapsilosis cells; tongue and palate samples of these two participants were yeast free 
(Table 3). The six oral samples (i.e. saliva, tongue and palate of participants CL9 and 
ML5) lacking any C. albicans or C. albicans/C. dubliniensis chimera cells had a high 
number of C. glabrata colonies instead. The three oral samples of the PAS-negative 
participant CL9 contained only C. glabrata (Table 3). However, the tongue and palate 
samples of the PAS-positive participant ML5 contained low counts of a second yeast 
species, C. tropicalis, which probably account for the hyphae observed in the PAS-
positive smears of those two oral samples. The PAS-positive participant SL3, not part of 
the selected group of 20 RH participants, was the only exception. That participant had 
very high number of only one yeast species, that was not C. albicans, a C. albicans/C. 
dubliniensis chimera or C. glabrata but Pichia anomala (Table 5). This interesting 
observation remains to be further investigated because, to the best of our knowledge, P. 
anomala, a relative of C. krusei, does not form hyphae although participant SL3 was 
PAS-positive. Thus, it is possible that we simply failed to detect C. albicans in participant 
SL3. C. albicans and C. glabrata were most frequently encountered together in the same 
sample; half (10 of 20) of all samples with two and five of six samples with three yeast 
species had C. albicans and C. glabrata. The only participant with four yeast species (C. 
 68 
albicans, C. glabrata, C. parapsilosis and P. fermentans) was an OH resident with low 
saliva flow (CL8; Table 3). 
 
Table 10. Species distribution in 70 yeast-positive oral samples from 13 OH and 16 RH 
participants (6 from Montecillo and 10 from LSOP) with one (left), two (centre) or a 
maximum of three (right) different yeast species a 
Group 
One species (44) Two species (20)b Three species (6)b 
Ca Ch Cg Cp Cl Ca Cg Cg Ca Ch Sc Cg Ca Ca Yl Cp Ca Ca Cg Ca Ca 
     Cg Ca Ch Sc Sc Ch Ct Cl Cgui Ca Ca Cg Cp Ca Sc Ch 
               Cg Cp Pf Sc Cg Cg 
OH 14  3 1 1        1 1 1 1 1 1    
Montecillo 4 4 1   2   1 2 1 2          
LSOP 16     5 3 1           1 1 1 
Total 34 4 4 1 1 7 3 1 1 2 1 2 1 1 1  1 1 1 1 1 1 
a Ca = C. albicans, Ch = C. albicans/C. dubliniensis chimera, Cg = C. glabrata, Cp = C. parapsilosis, Cl 
= C. lusitaniae, Ct = C. tropicalis, Cgui = C. guilliermondii, Sc = S. cerevisiae, Yl = Y. liplolytica, Pf = P. 
fermentas. 
b Species are listed according to their abundance with those above being more abundant than the species 
below. 
 
3.3.3 Multi Locus Sequence Typing of 87 Candida albicans isolates 
 
3.3.3.1 Diploid Sequence Typing. 
A selection of C. albicans strains from the participants was subjected to MLST. DNA 
oligomer primers for PCR amplification of the seven housekeeping genes and details of 
the seven amplicons that were used to determine the allele types and the DSTs are listed 
in Table 11. Frequently alleles of genes were found to differ by one or more single 
nucleotide polymorphisms (SNPs). The combination of allele types for the seven genes 
in a particular strain resulted in a specific DST. Generally, one to three strains from C. 
albicans-positive individuals were typed, but for two individuals, one with low saliva 
flow (CL1) and one with normal saliva flow (MN7), 15 strains were typed: 5 from saliva, 
5 from the tongue, and 5 from the palate. In total, 87 C. albicans strains were typed and 
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the DST for each strain determined. The 609 MLSTs of the seven genes of 36 C. albicans 
isolates from the 13 yeast-positive OH residents, 27 C. albicans isolates from the six 
yeast-positive Montecillo and 24 C. albicans isolates from the 10 yeast-positive LSOP 
participants are provided in Tables 12, 13 and 14, respectively. The allele types for each 
strain were recorded and are presented in Tables 12, 13 and 14, NM indicates a no match 
to any allele sequence type in the database. With these results 34 different DSTs could 
be distinguished for the 87 C. albicans isolates. The 34 unique DST were numbered for 
result analysis (Table 15). 
 
 
 
 
Table 11. MLST housekeeping gene information. 
a The seven housekeeping genes AAT1a to ZWF1b (H1-H7) are listed alphabetically.  
b Amplicon size and size of the entire ORF.  
c Chromosomal location. 
 
 
 
Genea Primer (5’ – 3’) Sizeb 
(bp) 
ORFb 
(bp) 
Chrc Position (bp)c 
AAT1a 
(H1) 
ACTCAAGCTAGATTTTTGGC 478 1314 II 1,077,700-1.079,013 
CAGCAACATGATTAGCCC 
ACC1 
(H2) 
GCAAGAGAAATTTTAATTCAATG 519 6816 R 155,196-162,011 
TTCATCAACATCATCCAAGTG 
ADP1 
(H3) 
GAGCCAAGTATGAATGATTTG 537 3117 R 1,248,944-1,245,828 
TTGATCAACAAACCCGATAAT 
MPIb 
(H4) 
ACCAGAAATGGCCATTGC 486 1326 II 1,972,394-1,973,719 
GCAGCCATGCATTCAATTAT 
SYA1 
(H5) 
AGAAGAATTGTTGCTGTTACTG 746 2910 VI 804,157-807,107 
GTTACCTTTACCACCAGCTTT 
VPS13 
(H6) 
TCGTTGAGAGATAATCGACTT 741 9252 IV 1,341,803-1,351,054 
ACGGATGGATCTCCAGTCC 
ZWF1b 
(H7) 
GTTTCATTTGATCCTGAAGC 702 1524 I 1,954,783-1,953,260 
GCCATTGATAAGTACCTGGAT 
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Table 12. DSTs of 36 C. albicans strains isolated from saliva, tongue or palate of 13 
(52%) participants living in their OHs that were colonized with C. albicans (66% or 6 of 
9 participants with low and 44% or 7 of 16 participants with normal saliva flow). 
a Number of allele type in database 
b No match with database allele types. 
 
 
 
 
 
 
Isolate Allele types for MLST genes a  
DST AAT1a ACC1 ADP1 MP1b SYA1 VPS13 ZWF1b 
CL1S1  NM b 3 NM 14 26 32 95 11 
CL1S2 NM 3 NM NM 26 32 12 3 
CL1S3 NM 3 43 14 26 32 12 2 
CL1S4 107 3 NM NM 26 32 95 1 
CL1S5 NM 3 43 14 26 32 12 2 
CL1T1 NM 3 NM NM 26 32 95 11 
CL1T2 NM 3 43 14 26 32 12 2 
CL1T3 NM 3 43 14 26 32 12 2 
CL1T4 NM 3 NM NM 26 32 95 11 
CL1T5 107 3 NM NM 26 32 95 1 
CL1P1 107 3 NM NM 26 32 95 1 
CL1P2 107 3 NM NM 26 32 NM 1 
CL1P3 NM 3 43 14 26 32 12 2 
CL1P4 178 3 NM NM 26 32 107 4 
CL1P5 NM 3 NM NM 26 32 95 1 
CL2S4 133 26 NM 14 6 104 268 18 
CL2T1 133 26 NM 4 6 104 58 19 
CL3S4 NM 3 10 NM 3 15 95 16 
CL3T4 NM 3 NM NM 3 15 95 17 
CL3P1 NM 3 NM NM 3 15 95 17 
CL4S5 143 14 NM NM 230 NM 6 24 
CL4T1 143 14 NM NM 230 NM 6 24 
CL4P1 143 14 NM NM 230 NM 6 24 
CL5S2 139 8 14 NM 72 NM 84 26 
CL8S4 NM 5 2 NM 2 24 16 28 
CL8T1 NM 5 170 NM 2 24 16 29 
CL8P1 NM 5 170 NM 2 24 16 29 
CN2S1 NM 3 NM NM 3 39 95 13 
CN3S1 NM 3 NM NM 3 32 95 15 
CN8S1 NM 3 NM NM 3 39 95 14 
CN9S1 143 14 NM NM 230 NM 6 24 
CN9P1 143 14 NM NM 230 NM 6 24 
CN12S1 NM 2 170 NM 2 20 5 13 
CN14S4 NM 5 170 4 2 6 5 30 
CN14T1 NM 5 170 4 2 6 5 30 
CN15S1 NM 3 43 NM 3 39 95 12 
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Table 13. DSTs of 27 C. albicans strains isolated from saliva, tongue or palate samples 
of 6 (46%) participants living in the Montecillo rest home that were colonized with C. 
albicans (66% or 4 of 6 participants with low and 29% or 2 of 7 participants with normal 
salivary flow) 
a Number of allele type in database 
b No match with database allele types. 
 
 
 
 
 
 
 
 
Isolate Allele types for MLST genes a  
DST AAT1a ACC1 ADP1 MP1b SYA1 VPS13 ZWF1b 
ML1S3 NM b 5 106 NM 51 132 12 27 
ML1T1 NM 5 NM NM 51 132 12 27 
ML1P1 NM 5 106 NM 51 132 12 27 
ML2S4 NM 3 NM NM 3 3 95 10 
ML2T1 NM 3 NM NM 3 39 95 14 
ML2P4 NM 3 NM NM 3 39 95 14 
ML3S5 NM 4 NM NM 4 4 4 23 
ML3T1 NM 3 NM NM 3 39 45 14 
ML4S3 NM 3 NM NM 67 3 95 6 
ML4T4 NM 3 NM NM 67 39 95 7 
ML4P1 NM 3 NM NM 67 39 95 9 
MN4S5 NM 3 NM NM 26 39 95 8 
MN7S1 NM 23 NM NM 2 6 5 34 
MN7S2 NM 23 NM NM 2 6 5 34 
MN7S3 NM 23 NM NM 2 6 5 34 
MN7S4 NM 23 NM NM 2 6 5 34 
MN7S5 NM 23 NM NM 2 6 5 34 
MN7T1 NM 23 NM NM 2 6 5 34 
MN7T2 NM 23 NM NM 2 6 5 34 
MN7T3 NM 23 NM NM 2 20 5 32 
MN7T4 NM 23 NM NM 2 6 5 34 
MN7T5 NM 23 NM NM 2 20 5 32 
MN7P1 NM 23 NM NM 2 6 5 34 
MN7P2 NM 23 NM NM 2 6 5 34 
MN7P3 NM 23 NM NM 2 6 5 34 
MN7P4 NM 23 NM NM 2 6 5 34 
MN7P5 NM 23 NM NM 2 6 5 34 
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Table 14. DSTs of 24 C. albicans strains isolated from saliva, tongue or palate samples 
of 10 (91%) participants living in LSOP RH that were colonized with C. albicans (88% 
or 7 of 8 participants with low and 100% or 3 of 3 participants with normal saliva flow). 
a Number of allele type in database 
b No match with database allele types. 
 
There were 74 positions in the housekeeping genes (H1 – H7; 3535 bp) for the 87 C. 
albicans isolates at which SNPs were found (Figure 4). 
 
 
Isolate Allele types for MLST genes a  
DST AAT1a ACC1 ADP1 MP1b SYA1 VPS13 ZWF1b 
SL1S1 NM b 3 NM NM 3 32 95  
SL2S2 NM 4 NM 4 4 4 22 22 
SL2T1 NM 4 NM 4 4 4 22 22 
SL2P1 NM 4 NM 4 4 4 22 22 
SL4S4 107 3 NM NM 3 39 95 5 
SL4P2 107 3 NM NM 3 39 95 5 
SL5S1 NM 3 NM NM 3 39 95 14 
SL6S5 4 22 6 NM 64 293 15 25 
SL7S2 NM 3 NM NM 3 39 95 14 
SL7T1 NM 3 NM NM 3 39 95 14 
SL7P1 NM 3 NM NM 3 3 95 10 
SL8S5 4 7 NM NM 74 4 22 20 
SL8T1 4 7 NM NM 74 4 22 20 
SL8P1 4 7 NM 19 74 4 22 21 
SL9S5 107 3 NM NM 3 39 95 5 
SN1S1 NM 3 NM NM 3 39 95 14 
SN1T1 NM 3 NM NM 3 39 95 14 
SN1P1 NM 3 NM NM 3 39 95 14 
SN2S1 NM 3 6 NM 2 6 5 33 
SN2T1 NM 3 6 NM 2 6 5 33 
SN2P1 NM 3 6 NM 2 6 5 33 
SN3S3 NM 3 NM NM 14 39 95 14 
SN3T4 NM 3 NM NM 3 NM 95 14 
SN3P1 NM 3 NM NM 3 3 95 10 
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MLST core sequence alignments of 87 Candida albicans isolates 
from eldery people living in their own home (C) 
or at Little Sisters of the Poor (L) or Montecillo (M) rest homes.
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Figure 4 Sequence alignment of the 74 nucleotide positions within the seven housekeeping 
genes (H1-H7) at which SNPs occurred in the 87 C. albicans isolates. Thirty-four different 
DSTs were distinguished. Housekeeping gene H1 had 9, H2 5, H3 13, H4 10, H5 11, H6 
15 and H7 11 positions at which nucleotides differed (SNP). 
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The sequences of the 609 individual genes were submitted to the C. albicans MLST 
database and 34 different DSTs were identified for the 87 C. albicans isolates (Figure 4, 
Table 15). All of these DST were unique to the study strains: none of the DST were in 
the database. 
 
Table 15. Diploid Sequence Types (DSTs) of 87 C. albicans isolates. 
DST № isolates Isolate 
1 5 CL1S4, CL1T5, CL1P1, CL1P2, CL1P5 
2 5 CL1S3, CL1S5, CL1T2, CL1T3, CL1P3 
3 1 CL1S2 
4 1 CL1P4 
5 3 SL4S4, SL4P2, SL9S5 
6 1 ML4S3 
7 1 ML4T4 
8 1 MN4S5 
9 1 ML4P1 
10 3 SL7P1, SN3P1, ML2S4 
11 3 CL1S1, CL1T1, CL1T4 
12 1 CN15S1 
13 1 CN2S1 
14 12 CN8S1, SL5S1, SL7S2, SL7T1, SN1S1, SN1T1, SN1P1, SN3S3, 
SN3T4, ML2T1, ML2P4, ML3T1 
15 2 CN3S1, SL1S1 
16 1 CL3S4 
17 2 CL3T4, CL3P1 
18 1 CL2S4 
19 1 CL2T1 
20 2 SL8S5, SL8T1,  
21 1 SL8P1 
22 3 SL2S2, SL2T1, SL2P1 
23 1 ML3S5 
24 5 CL4S5, CL4T1, CL4P1, CN9S1, CN9P1 
25 1 SL6S5 
26 1 CL5S2 
27 3 ML1S3, ML1T1, ML1P1 
28 1 CL8S4  
29 2 CL8T1, CL8P1 
30 2 CN14S4, CN14T1 
31 1 CN12S1 
32 2 MN7T3, MN7T5 
33 3 SN2S1, SN2T1, SN2P1 
34 13 MN7S1, MN7S2, MN7S3, MN7S4, MN7S5, MN7T1, MN7T2, MN7T4, 
MN7P1, MN7P2, MN7P3, MN7P4, MN7P5 
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3.3.3.2 Candida albicans microevolution  
The genetic variation of C. albicans strains within the same participant and between 
participants was investigated. This was done by identifying SNPs (which appear as 
double peaks on the sequencing chromatograms) for each of the housekeeping genes for 
a particular strain and seeing whether this heterozygosity (D = diploid) was present at the 
positions in those genes in other strains or whether those strains had one or other of the 
two SNP bases (A haplotype or B haplotype). Thus, for each gene in each strain there 
could be particular haplotypes (A or B) where both alleles were the same, or they could 
contain SNP(s) meaning that the two alleles were different (D). If, for genes in particular 
strains, several SNPs all lost their heterozygosity and became equivalent to an A or B 
allele, this indicated that a region of one allele had become duplicated in daughter cells, 
due to crossing over during DNA replication, a process called “loss of heterozygosity” 
(LOH). The analysis of the allele types in strains are presented in Tables 16-18 below. 
 
Table 16. Microevolution of C. albicans strains in participants with normal saliva flow 
(only those participants who had more than one C. albicans isolate sequenced are 
included). 
Patient Isolates† 
Genea 
AAT1a 
Chr2 
ACC1 
ChrR 
ADP1 
ChrR 
MP1b 
Chr2 
SYA1 
Chr4 
VPS13 
Chr6 
ZWF1b 
Chr1 
CN9 S1 B2 D2 D3 D2 D3 D3 D3 P1 B2 D2 D3 D2 D3 D3 D3 
CN14 S4 D3 D3 D4 B1 B1 D7 D6 T1 D3 D3 D4 B1 B1 D7 D6 
SN1 
S1 D1 A1 D1 D1 D2 D6 D1 
T1 D1 A1 D1 D1 D2 D6 D1 
P1 D1 A1 D1 D1 D2 D6 D1 
SN2 
S1 D3 A1 B3 D7 B1 D7 D6 
T1 D3 A1 B3 D7 B1 D7 D6 
P1 D3 A1 B3 D7 B1 D7 D6 
SN3 
S3 D1 A1 D1 D1 D2 D6 D1 
T4 D1 A1 D1 D1 D2 D6 (T) D1 (T) 
P1 D1 A1 D1 D1 D2 B3 D1 
† S, T and P followed by a number (1 to 5) are strain names for the saliva, tongue or palate isolates. 
a Haploid sequence types on blue background indicate LOH (loss of heterozygosity) and (T) 
indicates triploid sequences with 1:2 SNP ratios due to duplication of one chromosome. A, B and 
D with a number indicate the various haploid (A or B allele) or diploid (D) sequence types. 
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In Tables 16-18, the number following the letters A, B or D indicates the level of 
similarity between each gene sequence for example; D2 is most similar to D1, while D8 
is the least similar to D1. Participants with normal salivary flow did not show much 
genetic change (Table 16). Only one participant, SN3, had aneuploidies (unusual number 
of chromosomes – usually three instead of two) in Chr 1 and Chr 6 in SN3T4, while 
SN3P1 had the loss of the A allele in Chr 6. Due to these changes, participant SN3 was 
colonised with 3 versions of the same strain with 2 DSTs:  DST14 for SN3S3 and SN3T4 
and DST10 for SN3P1 (Table 15).  
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Table 17. Microevolution of C. albicans strains in participants with low saliva flow (only 
those participants who had more than one C. albicans isolate sequenced are included). 
Patient Isolates† 
Genea 
AAT1a 
Chr2 
ACC1 
ChrR 
ADP1 
ChrR 
MP1b 
Chr2 
SYA1 
Chr4 
VPS13 
Chr6 
ZWF1b 
Chr1 
CL2 S4 B1 D1 D2 B1 D1 D1 B2 T1 B1 D1 D2 B1 D1 D1 D2 
CL3 
S4 D1 A1 A2 D1 D2 D2 D1 
T4 D1 A1 D1 D1 D2 D2 (T) 
D1 
(T) 
P1 D1 A1 D1 D1 D2 D2 D1 
CL4 
S5 B2 D2 D3 D2 D3 D3 D3 
T1 B2 D2 D3 D2 D3 D3 D3 
P1 B2 D2 D3 D2 D3 D3 D3 
CL8 
S4 D3 D3 B2 D4** B1 B1 D5 
T1 D3 D3 D4 D5 B1 B1 D5 
P1 D3 D3 D4 D5 B1 B1 D5 
SL2 
S2 D4 D4 D5 B1 D5 B2 B3 
T1 D4 D4 D5 B1 D5 B2 B3 
P1 D4 D4 D5 B1 D5 B2 B3 
SL4 S4 A1 A1 D1 D1 D2 D6 D1 P2 A1 A1 D1 D1 D2 D6 D1 
SL7 
S2 D1 A1 D1 D1 D2 D6 D1 
T1 D1 A1 D1 D1 D2 D6 D1 
P1 D1 A1 D1 D1 D2 B3 D1 
SL8 
S5 B3 D6 D6 D6 D7 B2 B3 
T1 B3 D6 D6 D6 D7 B2 B3 
P1 B3 D6 D6 B2 D7 B2 B3 
ML1 
S3 D5 D3 D7 D7 D8 D8 A1 
T1 D5 D3 D7 D7 D8 D8 A1 
P1 D5 D3 D7 D7 D8 D8 A1 
ML2 
S4 D1 A1 D1 D1 D2 B3 D1 
T1 D1 A1 D1 D1 D2 D6 D1 
P4 D1 A1 D1 D1 D2 D6 D1 
ML3 S5 D4 D4 D5 B1 D5 B2 D8 T1 D1 A1 D1 D1 D2 D6 D1 
ML4 
S3 A1 A1 D1 D1 B2 B3 D1 
T4 A1 A1 D1 D1 B2 D6 D1 
P1 D1 A1 D1 D1 B2 D6 D1 
† S, T and P followed by a number (1 to 5) are strain names for the saliva, tongue or palate isolates. 
a Haploid sequence types on blue background indicate LOH (loss of heterozygosity) and (T) 
indicates triploid sequences with 1:2 SNP ratios due to duplication of one chromosome. A, B and 
D with a number indicate the various haploid (A or B allele) or diploid (D) sequence types. 
** Partial LOH (i.e. only the 3’ half of H4 (MP1b) of CL8S4 experienced LOH). 
 
 
However, more participants with low salivary flow had strains with evidence of 
microevolution (8 out of 12 participants; Table 17). Most of the genetic changes involved 
LOH, thus increasing the number of variations of the same C albicans strain within the 
same participant.  
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Table 18. Microevolution of 15 C. albicans isolates from the saliva, tongue and palate 
samples of two participants, one with a low (CL1) and the other one with normal saliva 
flow rate (MN7). 
Patient Isolates† 
Genea 
AAT1a 
Chr2 
ACC1 
ChrR 
ADP1 
ChrR 
MP1b 
Chr2 
SYA1 
Chr4 
VPS13 
Chr6 
ZWF1b 
Chr1 
CL1 
S1 D1 A1 D1 (T) D1 A1 A1 D1 (T) 
S2 D1 A1 D1 D1 A1 A1 A1 
S3 D1 A1 A1 A1 A1 A1 A1 
S4 A1 A1 D1 D1 A1 A1 D1 
S5 D1 A1 A1 A1 A1 A1 A1 
T1 D1 A1 D1 D1 A1 A1 D1 
T2 D1 A1 A1 A1 A1 A1 A1 
T3 D1 A1 A1 A1 A1 A1 A1 
T4 D1 A1 D1 D1 A1 A1 D1 
T5 A1 A1 D1 D1 A1 A1 D1 
P1 A1 A1 D1 D1 A1 A1 D1 
P2 A1 A1 D1 D1 A1 A1 D1 
P3 D1 A1 A1 A1 A1 A1 A1 
P4 A1 A1 D1 D1 A1 A1 B1 
P5 A1 A1 D1 D1 A1 A1 D1 
MN7 
S1 B1 D7 D4 D7 B1 D7 D6 
S2 B1 D7 D4 D7 B1 D7 D6 
S3 B1 D7 D4 D7 B1 D7 D6 
S4 B1 D7 D4 D7 B1 D7 D6 
S5 B1 D7 D4 D7 B1 D7 D6 
T1 B1 D7 D4 D7 B1 D7 D6 
T2 B1 D7 D4 D7 B1 D7 D6 
T3 B1 D7 D4 D7 B1 A2 D6 
T4 B1 D7 D4 D7 B1 D7 D6 
T5 B1 D7 D4 D7 B1 A2 D6 
P1 B1 D7 D4 D7 B1 D7 D6 
P2 B1 D7 D4 D7 B1 D7 D6 
P3 B1 D7 D4 D7 B1 D7 D6 
P4 B1 D7 D4 D7 B1 D7 D6 
P5 B1 D7 D4 D7 B1 D7 D6 
† S, T and P followed by a number (1 to 5) are strain names for the saliva, tongue or palate isolates. 
a Haploid sequence types on blue background indicate LOH (loss of heterozygosity) and (T) 
indicates triploid sequences with 1:2 SNP ratios due to duplication of one chromosome. A, B and 
D with a number indicate the various haploid (A or B allele) or diploid (D) sequence types. 
 
 
 
In participant CL1, there were 6 different versions of the same strain with 5 different 
DSTs and one possible aneuploid strain. CL1T1 and CL1T4 isolates of DST11 (Table 
15) were quite possibly closest to the diploid C. albicans strain type from which all 5 
other DSTs evolved over time in participant CL1. CL1S1 DST11 (Table 15) quite 
possibly evolved from CL1T1 or CL1T4 by duplicating one copy each of ChrR and Chr1 
 79 
(chromosomal duplication does not change the DST). DST3 (CL1S2) and DST1 (CL1S4, 
-T5, -P1, -P2, -P5; Table 15) probably evolved from DST11 (i.e. CL1T1 or -T4) by LOH 
(loss of B allele) in H7 (ZWF1b) and H1 (AAT1a), respectively. DST2 (CL1S3, -S5, -
T2, -T3, -P3; Table 15) most likely evolved from DST3 (CL1S2) by LOH of H3 and H4 
(loss of B alleles) on ChrR and Chr2, respectively. DST4 C. albicans cells of participant 
CL1 (CL1P4; Table 15) most likely evolved from DST1 by LOH of H7 (loss of A allele). 
Thus, one C. albicans isolate (S1) of participant CL1 experienced aneuploidies in Chr1 
and ChrR, another isolate (S2) experienced LOH of H7, five isolates (S4, T5, P1, P2, P5) 
are derivatives of a cell that experienced LOH of H1, five isolates (S3, S5, T2, T3, P3) 
are derivatives of a cell that experienced an additional two LOH events of H3 and H4 of 
a cell that shared its ancestry with isolate S2, and one isolate (P4) experienced an 
additional LOH event in H7 from an isolate that shared its ancestry with S4. Thus, all 15 
C. albicans isolates of CL1 are probably offspring of a single DST11 cell that has 
undergone significant microevolution (i.e. one aneuploidy and four separate LOH events 
(i.e. one in H1, H3 and H4 and two in H7) over a period of time. 
 
Hardly any microevolution was detected in 15 C. albicans isolates characterized from 
another participant (MN7) with a normal saliva flow rate (Table 18). Similar to CL1, all 
15 C. albicans isolates of participant MN7 were clearly derived from a single ancestor in 
their distant past. Thirteen isolates were identical (DST34; Table 15), and two isolates 
(MN7T3, -T5; Table 18) were offspring of the same DST34 cell that had experienced a 
single LOH event in Chr6 in the recent past. 
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3.3.3.3 The relatedness of Candida albicans strains  
The phylogenetic relatedness of the 87 C. albicans isolates is depicted in Figure 5. The 
phylogenetic tree shows the genetic similarity between all C. albicans strains sequenced.  
The strains from RH and OH participants appear to be randomly distributed across all 
branches of the phylogenetic tree and so are not closely related. 
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Figure 5 Phylogenetic tree of the 3535 bp concatenated housekeeping gene sequences of 
87 C. albicans isolates isolated from the indicated participants. The tree revealed no 
geographical clustering of strains isolated from LSOP (blue) or Montecillo (magenta) 
RHs compared to the control participants living in their OHs (green). 
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3.3.3.4 Hybrid strains between C. albicans and C. dubliniensis 
Quite to our surprise, nine “C. albicans” strains isolated from four RH participants (three 
from Montecillo and one from LSOP) appeared to in fact be C albicans/C. dubliniensis 
hybrid strains (ML3P1, MN2S4, -T4, -P1, MN5S1, -T1, -P1 and SL4T1, -P1) . Two of 
these participants had low salivary flow rate, the other two had normal salivary flow rate. 
Four of the nine hybrid strains were isolated from the palate, three from the tongue and 
two from saliva samples. The strains within the same participant were very similar or 
identical to each other (see Appendix X). However, the hybrid strains between the four 
participants were quite different, suggesting four separate hybridization events. 
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Chapter 4: Discussion 
 
4.1 Introduction 
 
The focus of this study was the oral health of older people. The objective was to 
investigate if living conditions would have an impact on the yeast colonization in the oral 
cavities of the older people. Evaluation of the methodological approaches, the results in 
relation to relevant literature, limitations of the study and future directions will be 
discussed in this chapter. 
 
4.2 Sampling methods 
 
A cross sectional study was the preferred type of study for a pilot descriptive project such 
as this with no interventions. As such, it is an observational study at a specific point in 
time which analyses data from a population, or a subgroup(s) of the population. Ideally, 
all rest home participants should be from one establishment as this would remove any 
variable factor due to different processes being used at different rest homes. 
Unfortunately, the largest rest home in Dunedin declined to participate in this study. The 
other rest homes had a lower capacity, thus the need for two rest homes to provide 
sufficient participants, 13 from Montecillo Rest Home and 12 from Little Sisters of the 
Poor. 
The results indicated that participants in both rest homes had higher levels of yeast 
colonization than participants living at home. Although participants from both rest homes 
had high levels of colonization, participants from Little Sisters of the Poor had, on 
average, significantly higher levels of colonization. Despite this difference in 
colonization levels, strain typing revealed that isolates from each rest home were 
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dispersed across the phylogenetic tree indicating that having two different rest homes did 
not influence the results of this study greatly. However, future studies should aim to 
involve participants from a single rest home. 
 
4.3 Study participants 
 
The number of participants recruited from each population group was 25. To remove age 
as a confounding factor, 20 participants from each group were selected that were matched 
as best as possible for age and gender, without taking any other factor into consideration. 
This selection resulted in an RH group with mean age of 86.0 compared to 83.1 for those 
living in their OH, this difference was not statistically significant. This mean age for RH 
participants corresponds with the Statistics New Zealand data from 2013 which states 
that 72% of RH residents were above the age of 80 (Statistics New Zealand, 2013) and 
that 50% of New Zealanders live in RHs by the age of 85 (Broad et al., 2015). Older 
people are encouraged to remain independent and to continue living in their OHs for as 
long as possible. So, although we were able to get older community dwelling participants 
age-matched to those in RHs we had to exclude younger OH participants and older RH 
participants to achieve the matching. Thirteen participants of each group (65%) were 
female and 7 (35%) were male, this reflects the fact that more than two-thirds of people 
in residential care for older people are female, 68.1% (Statistics New Zealand, 2013).  
To get a better understanding of the yeast species variation and distribution in the two 
populations, data from all 25 participants from each group were used in the MLST DNA 
sequencing analysis. 
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4.4 Yeast colonization 
 
Saliva was the most highly colonized oral site sampled, followed by the tongue and the 
palate was the least colonized. Compared to the tongue and palate, saliva was the most 
frequently colonized site as well. This may be due to the salivary function of oral 
clearance (Humphrey & Williamson, 2001), whereby yeast colonizing other parts of the 
oral cavity are washed off into saliva. Saliva, therefore, may be used as an indicator of 
the state of colonization in the oral cavity in the study of yeast species variety. The level 
of yeast colonization for each site was much higher in RH participants, even though there 
were no significant differences in terms of age, salivary flow, denture use, and number 
of medications taken by participants in the two groups. This may be because participants 
in RH are frailer and require assistance in activities of daily living including oral hygiene 
care, while participants in OH are more independent and more able to care for 
themselves. This study indicates that there is a need for good oral care in RHs. The New 
Zealand Dental Association (NZDA) in January 2011 published ‘Healthy Mouth, 
Healthy Ageing: Oral Health Guide for Caregivers of Older People’ which is free to 
download from the Ministry of Health website 
(https://www.health.govt.nz/publication/healthy-mouth-healthy-ageing). The NZDA has 
also claimed to have carried out training for 4000 caregivers to date.  However, there is 
currently no framework to evaluate any form of best practice protocol for oral hygiene 
care in RHs. Dietary factor may contribute to a much higher yeast colonization in RH 
participants. Older people living in rest homes have meals prepared for them but have 
limited input or choice on the types of food served (Abbey, Wright, & Capra, 2015).  
Some older people face complex nutritional problems which arise during the progressive 
decline in cognitive, behavioural and physical functions. Some rest homes resort to food 
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high in carbohydrate and sugar to encourage food intake, however, research on this is 
limited.  
 
 
4.4.1 Dentures 
A high number of participants were denture wearers; 70% of RH participants and 55% 
who were living at home (this difference is not significant). This corresponds with the 
NZ Older People Oral Health Survey 2012 which found 70% of edentulous people wore 
dentures (Smith, Thomson, & Gribben, 2012). A significantly larger proportion (84%) 
of denture wearing participants presented with yeast positive saliva while yeast was only 
present in 53% of non-denture wearing participants. This is consistent with a study by 
Pereira Lyon et al., 2006, which showed a higher percentage of denture wearers had 
Candida carriage compared to non-denture wearers. 
Denture use is a risk factor to candidiasis (C. S. Farah et al., 2018). Poor denture hygiene, 
overnight denture use, dentures with poor retention and/or stability and worn-down 
dentures which reduce vertical dimension are factors that increase risk of candidiasis. 
Dentures may also provide a surface that promotes Candida adherence. 
 
4.4.2 Salivary Flow 
Salivary function studies may be carried out by: 
i) Sialometry: measuring salivary flow rates 
- whole unstimulated saliva: the collection of saliva at rest, closely relates 
with symptoms of salivary gland hypofunction 
- stimulated saliva: the collection of saliva after stimulation (chewing, sucking 
or eating) 
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- selective saliva from specific glands: the collection of stimulated saliva from 
the duct opening of parotid, submandibular and sublingual gland using 
specialised collection apparatus 
ii) Ultrasonography 
- able to detect changes to major salivary glands during inflammation  
            - non-invasive, high specificity and moderate sensitivity 
iii) Sialography  
            - introduction of radio-opaque dye into the salivary duct  
            - able to detect dilation or duct obstruction  
            - non-specific with risks of discomfort and infection 
iv) Salivary scintiscanning  
            - examines all major salivary glands simultaneously 
            - small radiation hazard  
            - not always available and expensive 
v) Salivary gland biopsy                                                       
(Scully & Scully, 2013) 
The whole unstimulated saliva flow rate test was chosen for this study because it is a 
simple, generally acceptable and non-invasive method of investigating overall 
salivary output. 
 
There was no significant difference between RH and OH participants in terms of their 
mean salivary flow rate (0.23 ml/min vs 0.25 ml/min, respectively). However, this study 
confirmed an association between low salivary flow rate and increased yeast colonization 
in the oral cavity and hyphae-positive smears as previously reported (Nadig et al., 2017) 
(Shinozaki et al., 2012). Older people in general suffer from reduced salivary flow. As 
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discussed in Chapter 1 (1.2.4.3) it is important to manage hyposalivation in all patients 
with low salivary flow.  This reduces the risk of developing candidiasis as well as 
realising the many benefits of a moist mouth. 
 
4.4.3 Medication 
There was no significant difference in the numbers of medications taken by RH 
participants and OH participants. However, participants with low salivary flow rate were 
taking, on average, more medications per day than those with normal salivary flow rate. 
Hyposalivation due to medication has been reported for older populations by numerous 
authors (Smidt, Torpet, Nauntofte, Heegaard, & Pedersen, 2011)(Lynge Pedersen et al., 
2015). As people age, their health declines, and there is a corresponding increase in the 
number of medications prescribed to manage their conditions (Barbe, 2018). Clinicians 
prescribing these medications should develop a proactive approach to manage the 
common side effects of these medications, such as reduced salivary function.  
 
4.4.4 Hyphae-positive smears 
A third of participants (13) had hyphae-positive smears. There was no significant 
difference in the prevalence of hyphae-positive smears between participants living at 
home to those living in RHs. Most participants with hyphae-positive smears were denture 
wearers and had a low salivary flow rate (<0.2 ml/min). Hyphae-positive smears are 
indicative of candidiasis as hyphae are required to penetrate host tissues. These results 
are consistent with denture wearing, and low salivary flow, increasing the risk of 
candidiasis. Almost all participants with hyphae-positive smears had high concentrations 
of yeast in their saliva (>400 cfu/ml), this confirms the report by Epstein, Pearsall, & 
Truelove, 1980.  
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4.4.5 Species variation 
C. albicans was the species found most frequently in participant samples from both 
groups followed by C. glabrata. Interestingly, many other yeast species, some of which 
are not commonly associated with the oral cavity were identified. Participants living in 
their OH had C. parapsilosis, C. lusitaniae, C. guilliermondii, Pichia fermentans and 
Yarrowia lipolytica in addition to C. albicans and C. glabrata in their oral cavities. While 
Saccharomyces cerevisiae, C. dubliniensis, C. tropicalis and C. albicans/C. dubliniensis 
chimera strains were the other species identified in RH participant samples. It is 
interesting that C. albicans and C. glabrata were the only two yeast species found in both 
groups; the rest were found in either the OH or the RH participants. This may be due to 
the small size of this study population, and low incidence of the non-albicans non-
glabrata species. It may also be because C. albicans has successful commensal traits like 
adherence to buccal epithelial cells, biofilm formation, production of hydrolytic enzymes 
and haemolytic activity compared to other species (Deorukhkar, Saini, & Mathew, 2014). 
Many of the yeast species found in this study have been reported as having either intrinsic 
or acquired resistance to antifungals for example C. albicans, C. glabrata, C. 
parapsilosis, C. lusitaniae, C. guilliermondii, C. tropicalis, and Y. lipolytica (Atkinson 
et al., 2008)(Papon, Courdavault, Clastre, & Bennett, 2013)(Meurman et al., 2011)(Zhao 
et al., 2015). It is not known if any of the yeast species and C albicans strains identified 
in this study are resistant to antifungal agents. 
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4.5 Presumptive identification of Candida species with CHROMagar™ Candida 
Agar 
 
CHROMagar™ Candida agar is a simple and reliable tool to quantify yeast colonization. 
It is also valuable for presumptively identifying different yeast species. Growth on  
CHROMagar™ Candida medium results in colonies with distinctive colours which, 
according to the manufacturer’s manual for identification, are C. albicans green, C. 
tropicalis blue, and C. krusei pale rose. In this study we have found in some instances 
two shades of green, or two distinctively different sizes of green colonies present on the 
same plate. Our further investigation of green colonies by rDNA sequencing, revealed 
that there was no species difference between different shades or sizes of colonies of the 
same colour within the same participant. However, we were not able to distinguish 
between C. albicans and C. dubliniensis or a hybrid strain of these two species with this 
method, as they all formed green colonies.  
 
4.6 Smear Test 
 
The smear test with PAS staining is a simple and effective method to identify fungal 
hyphae indicative of fungal invasion into host tissues. A PAS-positive smear indicates to 
the clinician that there is active fungal infection and that investigations are required to 
determine any predisposing factors and that antifungal medication is required. A smear 
allows a direct diagnosis of candidiasis but is limited to hyphae-forming fungi such as C. 
albicans and C. tropicalis. Many fungi, such as C. glabrata, are not capable of forming 
hyphae but can still cause candidiasis. The smear test is unable to distinguish species type 
based on the morphology of organism observed.  A positive smear test may need to be 
reclassified as ‘hyphae positive’. A negative smear test (no hyphae observed) which has 
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yeast-like cells present may need further investigation. Plating swab suspension or saliva 
on CHROMagar plates may identify non-hyphae forming fungi, and high numbers of 
CFU (≥400/ml) indicates active fungal infection. A truly negative smear test (no hyphae 
or yeast-like cells observed) indicates no fungal infection. In this study, DNA analysis 
indicated that C. albicans was the yeast most commonly found in samples. Hyphae-
positive smears was found in about one third of the participants. All participants with 
PAS-positive smears were C. albicans-positive except for two participants; ML5 (had C 
tropicalis present which can form hyphae) and MN5 (had S cerevisiae which forms 
pseudo-hyphae, and also a chimera strain - a mix of C albicans and C dubliniensis). Thus, 
the smear test is not an absolute diagnostic tool for candidiasis but, as C. albicans is the 
most common cause of candidiasis, it is a useful clinical tool. We also observed a PAS-
positive smear in SL3 which only had Pichia anomala (a non-hyphae forming organism) 
growth on CHROMagar™ Candida agar. C. albicans may have been present in the smear 
(as detected with PAS) and swab. However, the C. albicans growth on CHROMagar™ 
Candida agar may have been inhibited by Pichia anomala toxins (Mathews, Conti, 
Witek-Janusek, & Polonelli, 1998). 
 
4.7 Precise identification of yeast species 
 
Non-albicans species isolates presumptively identified from growth on CHROMagar™ 
Candida agar were subjected to DNA sequencing of the internal transcribed spacer (ITS) 
region in the ribosomal RNA (rRNA) operon. This ITS region has been accepted as the 
formal fungal barcode (Op De Beeck et al., 2014)(Hoggard Michael et al., 2018) with a 
large database of sequences available at https://www.ncbi.nlm.nih.gov/BLAST. This 
study has provided a rare glimpse into the diverse yeast species present in the oral cavity. 
It is also interesting to note that most people have only one fungal species present in their 
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mouth at any one time. When two species are found together, they are usually C. albicans 
and C. glabrata. They are both successful commensals and pathogens in humans, yet 
they are different to one another in terms of phylogeny, genetics and phenotype (Brunke 
& Hube, 2013). It is not known if these Candida species being present in the same niche 
makes them less susceptible to antifungal agents.  
 
4.8 Multi Locus Sequence Typing (MLST) 
 
MLST using the DNA sequences of seven housekeeping genes was a very useful tool to 
compare the C. albicans strains present in the oral cavities of individuals. It is however 
time consuming, resource intensive, and requires a high level of skill and knowledge in 
the field of microbiology. The value of this technique is that MLST data from different 
studies worldwide are centralized in public databases, allowing the comparison of strains 
from all over the world.  The PubMLST database website is currently recognized as the 
most complete repository for MLST data (Muñoz et al., 2019). 
 
4.8.1 Candida albicans strains 
A total of 87 C. albicans strains were isolated from the participants in this study. Many 
of the strains were identical according to the MLST Diploid Sequence Type (DST) and 
there were 34 different DSTs. None of the 34 DSTs was a match to the strains contained 
in the database at https://pubmlst.org/calbicans. This database does not represent all 
global isolates because the data are voluntarily submitted by researchers aware of the 
database. It is, however, a scientifically valuable dataset as it is the largest repository of 
C. albicans strain types (Muñoz et al., 2019). The database was last updated on 9/10/2018 
and contains a total of 4,392 isolates. In the past, the database was updated 3-4 times a 
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year. All 34 DSTs from this study have been submitted to be added to the database but, 
at the time of printing this thesis, we have yet to receive a confirmation that the DST 
have been entered. When they are entered, as they are not already present in the database, 
they will be assigned unique DST numbers. 
 
4.8.2 Microevolution of Candida albicans strains 
The genetic diversity of C. albicans is evident from this study. An interesting finding 
was a link between salivary flow rate and microevolution. Participants with low salivary 
flow rates had C. albicans strains in their oral cavities with more genetic changes like 
aneuploid gene alleles, loss of heterozygosity (either partial or full) and chromosomal 
duplications compared to strains from people with normal salivary flow rates. One 
explanation would be that C. albicans is constantly changing in people with low salivary 
flow rates to better adapt to that environment. We noted up to five variations of the same 
strain within one site in one participant. Participant CL1 (low salivary flow) had 6 
different versions of the same strain with 5 different DSTs while MN7 (normal salivary 
flow) had 2 different versions of the same strain with 2 DSTs. Most participants had only 
been colonized by one C. albicans strain in their oral cavity. The strains in participants 
colonized by more than one DST appear to have originated from the same ancestor strain 
which had undergone microevolution. This study has given us a first glimpse into the 
possible changes to the genetic code by comparing seven housekeeping gene sequences 
of up to five independent isolates from the same location in the oral cavity of an 
individual. We have also been able to compare the changes relative to strains in other 
locations in the oral cavity.  
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4.8.3 Relatedness of strains 
C. albicans strains from OH and RH participants were spread throughout the 
phylogenetic tree of strains. Living in close proximity to one another, sharing the same 
caregivers and food handlers, appeared to have no effect on the relatedness of the C. 
albicans strains present in the oral cavities of RH participants.  This strain diversity 
disproves one of the hypotheses (1.6) of this study. 
 
4.8.4 Hybrid strains 
Nine strains that appeared to be hybrids of C. albicans and C. dubliniensis were identified 
in four RH participants. Studies have shown that these strains are able to mate and 
produce stable hybrid in a laboratory setting (Pujol et al., 2004)(Chakraborty et al., 2013). 
Little is known about these strains in nature as they have never been reported. This may 
indicate that sexual reproduction occurs more frequently as a propagation method than 
commonly believed.  
   
 
 
4.9 Future studies 
 
The susceptibility of all yeast species identified in this study against antifungal agents 
needs to be investigated. The identification of resistant strains and prevalence (if any) 
would be vital information to ensure early detection of these resistant strains and 
contribute towards global surveillance efforts. In this study, nucleotide polymorphism 
was noted more frequently in participants with low salivary flow rate. It remains to be 
determined if these changes in the genetic code has  affected the amino acid sequence of 
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protein (Smith, 2008), potentially increasing the pathogenicity of C. albicans. The 
chimera strains identified in this study require confirmation and further investigation. It 
would be interesting to know why these strains were only found in RH participants and 
their susceptibility level to antifungal agents. 
 
4.10 Conclusions 
 
This study has shown that older people living in RH are more likely to be colonized by 
yeast, have a higher degree of yeast colonization as well as the prevalence of chimera 
strains compared to those living in their OH. Regardless of living conditions, older people 
wearing dentures, and those with low salivary flow, are at higher risk of yeast 
colonization and candidiasis. C. albicans and C. glabrata are the most common yeasts 
found in the oral cavity. C. albicans is associated with the majority of PAS-positive 
smears. Saliva may be used as an indicator for species variety in the oral cavity. C. 
albicans strains undergo more genetic changes in people with low salivary flow. 
Preventive care is the best way forward to maintain oral health of older people, some 
suggested strategies are as follows:  
i) Clinicians should be encouraged to include baseline salivary flow rate as part 
of the initial dental consultation for all older people and medically 
compromised patients. Information gathered will allow hyposalivation 
strategies (if needed) to be incorporated into the treatment plan. 
ii) Devise care plans encouraging best practice of oral health care in residential 
aged care facilities that can be implemented nationwide. 
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Appendix III: Patient Information Sheet 
 
 
 
Study title: Candida species and strains in the oral cavity of the elderly: a comparison 
between people in home-based care and in an aged care facility 
 
Principal 
investigator: 
Name : Nurulhuda Mohd Thiyahuddin 
Department : OralDiagnostic and Surgical 
Sciences 
Position : DClinDent Special Needs 
Candidate 
Contact phone number: 
03 4797025 
 
Introduction 
Fungal infection of the mouth is very common in the older people and people with 
symptoms of dry mouth.  The natural ageing process and effects of certain medications 
reduces saliva production which causes dry mouth. Fungal infection is also common in 
people who wear dentures.  
Fungus naturally present in the mouth is Candida which comes in many different 
species and strains. Candida is usually harmless.  However, when infection occurs the 
mouth becomes sore. This infection is then treated with antifungal medication.  
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Studies have shown that some Candida species are immune to certain antifungal drugs. 
We wish to find out which Candida species and strains can be found in the mouth of 
elderly participants.  
 Thank you for showing an interest in this project.  Please read this information sheet 
carefully. Take time to consider and, if you wish, talk with relatives or friends, before 
deciding whether or not to participate.  
If you decide to participate we thank you.  If you decide not to take part there will be no 
disadvantage to you and we thank you for considering our request.   
 
 
What is the aim of this research project? 
The aim of this project is to investigate and compare Candida species and strains between 
participants who live at home and those who live in an age care facility. The outcome of 
this study will contribute towards a better understanding of the risk of candida infection 
and better inform antifungal treatment protocols in elderly patients. 
 
Who is funding this project? 
This study is funded by the Ministry of Health.  
Who are we seeking to participate in the project? 
We need to sample two groups of elderly people: 
 1) people living at an age care facility; and 
 2) people living at home who may, or may not, be patients of the Special Care Unit, 
Faculty of Dentistry, University of Otago. 
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Enrolment of participants will be by voluntary participation after informed consent is 
obtained. 
Participants of this study must be: 
• Age 65 and above  
• Generally well or have well controlled medical conditions 
• Able to cooperate with the procedures 
• Able to give consent 
 
People who cannot participate are: 
• People who had used antibiotic/antifungal in the past 2 months 
• Terminally ill  
• Smokers 
 
 
If you participate, what will you be asked to do? 
We will examine your mouth. 
 You will need to collect saliva in your mouth for one minute then spit into a container. 
This will be repeated 5 times. If you are not able to do this, you will need to rinse your 
mouth with bottled water and spit into a container. 
A tissue swab will be done by gently rubbing your palate and tongue with a cotton bud.  
A tissue smear will be done by gently scraping your palate and tongue with a wooden 
spatula. 
The procedure will be done once and will take less than 15 minutes 
Is there any risk of discomfort or harm from participation? 
There will be no harm or discomfort to the participant. However, there is a risk that you 
might gag during the swab and smear taking procedure. Please inform us beforehand if 
you have a strong gag reflex. There is also a small risk of mucosal tear during smear 
taking.  This procedure will be done gently and quickly to reduce these risk.  
 123 
What specimens, data or information will be collected, and 
how will they be used?  
The investigator will collect information on your age, gender, medical history and if 
you wear dentures.  
The saliva and swab taken will be tested for presence of different types of Candida 
species and strains. The remainder of the sample will be stored securely until the 
completion of the project. The cotton bud will be disposed and the rest of the sample 
will then be destroyed by sterilisation. 
The smear taken will be spread onto a glass slide and stained. This will then be 
examined under a microscope. The remainder of the sample and the wooden spatula 
will be disposed. 
As samples of human tissue will be taken in this study, there may be cultural issues 
regarding tissue storage and disposal. We suggest that you involve your family/whanau 
at every stage of this research.  We acknowledge that you have the full authority to 
choose to participate in this study or not. If you would like to participate, you will first 
need to fill in a consent form. 
The data collected will be securely stored and only the people mentioned below are 
able to gain access to it. All personal information will be destroyed immediately at the 
end of the project except that as required by the University research policy. Raw health 
data will be retained in secure storage for ten years after which they will be destroyed. 
 
 
What about anonymity and confidentiality? 
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The result of this study will be reported and may be published. However, no material 
which could personally identify you will be used in the report.  
 
 
If you agree to participate, can you withdraw later? 
Your participation is entirely voluntary (your choice).  
You may withdraw from participation in the project at any time and without any 
disadvantage to yourself.  
 
 
Any questions? 
If you have any questions now or in the future, please feel free to contact either: 
Name   Nurul Thiyahuddin 
Position  DClinDent Candidate 
Department  Oral Diagnostic and Surgical Sciences 
Contact phone number: 
03 4797025 
Name   Richard Cannon 
Position  Director 
Department Sir John Walsh Research Institute 
Contact phone number: 
                     03 4797081 
 
This study has been approved by the University of Otago Human Ethics Committee 
(Health). If you have any concerns about the ethical conduct of the research you may 
contact the Committee through the Human Ethics Committee Administrator (phone +64 
3 479 8256 or email gary.witte@otago.ac.nz). Any issues you raise will be treated in 
confidence and investigated and you will be informed of the outcome. 
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Appendix IV: Consent Form 
 
 
Candida species and strains in the oral 
cavity of the elderly: a comparison 
between people in home-based care and 
in an aged care facility 
Consent form for participant  
Following signature and return to the research team this form will be stored in a secure place for ten 
years. 
Name of participant:………………………………………….. 
 
I have read the Information Sheet concerning this study and understand what it is about. 
All my questions have been answered to my satisfaction. I understand that I am free to 
request further information at stage. 
1. I confirm that I meet the criteria for participation which are explained in the 
Information Sheet. 
2. I know that my participation in the project is entirely voluntary, and that I am 
free to withdraw from the project at any time without disadvantage. 
3. I know that as a participant I will have to provide my medical records, have 
my saliva collected and mouth tissues swabbed and scraped. 
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4. I understand the nature and size of the risks of discomfort or harm which are 
explained in the Information Sheet. 
5. I know that when the project is completed all personal identifying information 
will be removed from the paper records and electronic files which represent 
the data from the project, and that these will be placed in secure storage and 
kept for at least ten years.  
6. I understand that the results of the project may be published and be available 
in the University of Otago Library, and that any personal identifying 
information will remain confidential between myself and the researchers 
during the study, and will not appear in any spoken or written report of the 
study.  
7. I know that there is no remuneration offered for this study, and that no 
commercial use will be made of the data.  
8. I understand that at the end of the study, any remaining samples will be 
disposed of using standard disposal methods.  
Signature of participant:  Date: 
   
   
 
Name of person taking consent  Date: 
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Appendix VI: Abstract for American Academy of Oral & 
Maxillofacial Pathology and International Association of Oral 
Pathology Congress 2018  
 
Poster Competition 24th to 28th June 2018 in Vancouver, Canada. 
 
Candida species and strains in the oral cavities of the elderly: a comparison between 
people in home-based care and in aged-care facilities 
Mohd Thiyahuddin N*, Cannon RD*, Lamping E*, Rich AM* 
*Sir John Walsh Research Institute, Faculty of Dentistry, University of Otago, Dunedin, 
New Zealand 
Oral candidiasis is prevalent in the elderly population due to medical conditions, use of 
systemic medications and the presence of oral appliances such as dentures. It is uncertain 
whether residing in an aged-care facility contribute to Candida carriage and has an 
impact on the Candida species or strains colonizing elderly patients. 
 
Objective: The aim of this study was to investigate the presence and abundance of 
Candida species and strains in saliva and from the oral mucosal swabs and smears of 
people living in institutional rest homes and those living at home.  
 
Method: Smears of the palate and tongue were taken from participants (rest home n = 
25 and control = 25) for histological analysis using PAS staining to identify the presence 
of hyphae. Unstimulated whole saliva and material obtained from swabs of palate and 
tongue were spread on CHROMagar plates and incubated at 37˚C for 48 hours. Candida 
species were identified by their colour, and colony forming units (CFU) were counted.  
 
Findings: A higher proportion of elderly people living in rest homes had PAS-positive 
hyphae present in smears (9/25, 38%) compared to those living in their own home (7/25, 
28%). CFU were present in 17/25 (68%) palatal swabs, 20/25 (80%) tongue swabs and 
in saliva from 21/25 (84%) of elders living in rest homes compared with 6/25 (24%) 
palatal swabs, 8/25 (32%) tongue swabs and from saliva in 16/25 (64%) of elderly living 
in their own home. 
 
Conclusion: The results indicate that elderly people living in aged-care facilities are 
more likely to have Candida hyphae detected on PAS-stained smears and have a higher 
Candida carriage rate compared to elderly living at home. This may be due to the 
presence of co-morbidities which led to the need for residential care and/or may be 
related to the rest home environment. 
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Appendix VII: Abstract for Malaysian International Dental 
Exhibition and Conference  
 
Oral Presentation, 14th July 2019 in Kuala Lumpur, Malaysia. 
 
2019 Malaysia-International Dental Exhibition and Conference (MIDEC) 
Presenter’s full name: Nurulhuda Mohd. Thiyahuddin 
Name of Institution: Sir John Walsh Research Institute, Faculty of Dentistry,             
                                   University of Otago, New Zealand 
Email address: nurul.thiyahuddin@otago.ac.nz 
Contact number: 0064 34797026 
Preferred mode of presentation: Oral (Window) 
I hereby certify that this abstract has never been published or presented. 
 
YEAST SPECIES IN THE ORAL CAVITIES OF OLDER PEOPLE:  
A COMPARISON BETWEEN PEOPLE LIVING IN THEIR OWN HOMES TO 
THOSE IN REST HOMES. 
Details of all authors: 
1) Nurulhuda Mohd. Thiyahuddin 
Sir John Walsh Research Institute, Faculty of Dentistry, University of Otago, Dunedin, 
New Zealand; nurul.thiyahuddin@otago.ac.nz 
2) Dr Erwin Lamping 
Sir John Walsh Research Institute, Faculty of Dentistry, University of Otago, Dunedin, 
New Zealand; erwin.lamping@otago.ac.nz 
3) Professor Alison Rich 
Sir John Walsh Research Institute, Faculty of Dentistry, University of Otago, Dunedin, 
New Zealand; alison.rich@otago.ac.nz 
 4) Professor Richard Cannon 
Sir John Walsh Research Institute, Faculty of Dentistry, University of Otago, Dunedin, 
New Zealand; richard.cannon@otago.ac.nz 
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Abstract:  
 
Aim: Oral candidiasis is prevalent among older people due to predisposing factors such 
as impaired immune defenses, use of xerogenic medications and dentures. An increasing 
number of older people live in rest home facilities and it is unclear how this 
institutionalized living affects the quantity and type of fungi colonizing these people’s 
oral cavities.  
 
Material and Methods: Smears and swabs of the palate and tongue and saliva samples 
were taken from participants residing in rest homes (RH; n = 20) and older people living 
in their own homes (OH; n = 20). Yeast in samples were quantified and identified by 
culturing on CHROMagar Candida and sequencing the ITS2 region of rDNA. 
 
Results: A higher proportion of RH residents had Candida hyphae present in smears 
compared to OH participants (35% vs 30%). RH residents had, on average, 23 times as 
many yeasts per ml saliva as OH participants. Seven yeast species were identified in OH 
samples and only five in RH samples, with Candida albicans and Candida glabrata being 
the most common species isolated from both participant groups. 
 
Conclusion: The results indicate that older people living in aged-care facilities were more 
likely to have candidiasis and have a higher yeast carriage rate than similarly aged people 
living at home. This may be due to morbidities which led to the need for residential care 
and/or related to the rest home environment. 
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Appendix VIII: Abstract for Australian Society of Special 
Needs in Dentistry Walkabout Conference 2019 ‘Caring 
Together’  
 
Oral Presentation, 19th July 2019 in Melbourne, Australia. 
 
Name of presenter: Nurul Thiyahuddin 
 
Title/degree: DClinDent Special Needs candidate 
 
Title of abstract: Yeast species in the oral cavities of older people 
 
List of authors/affiliations:  
NM Thiyahuddin, E Lamping, A Rich, RD Cannon 
Sir John Walsh Research Institute, Faculty of Dentistry, University of Otago 
 
Abstract: 
Oral candidiasis is prevalent among older people due to predisposing factors such as 
impaired immune defences, medications and denture use. An increasing number of older 
people live in rest home facilities and it is unclear how this institutionalised living affects 
the quantity and type of fungi colonizing these people’s oral cavities. Smears and swabs 
of the palate and tongue, and saliva samples were taken from participants residing in rest 
homes (RH; n = 25) and older people living in their own homes (OH; n = 25). Yeast in 
samples were quantified and presumptively identified by culturing on CHROMagar 
Candida agar. Sequencing of the ITS2 region of rDNA was carried out to confirm yeast 
species. Multilocus sequence typing (MLST) of 7 housekeeping genes was used to 
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compare Candida albicans strains. A higher proportion of RH residents had Candida 
hyphae present in smears compared to OH participants (35% vs. 30%) although this 
difference was not statistically significant (p = 0.74). RH residents had, on average, 23 
times as many yeast per mL saliva as OH participants (p = 0.01). C. albicans and C. 
glabrata being the most common species isolated from both participant groups. All C. 
albicans strains were similar within the same participant but very different between 
participants. C. albicans/Candida dubliniensis chimeras (hybrid strains) were found in 4 
rest home participants. The results indicate that communal living for those who reside in 
an age care facility has an impact on the abundance of yeast species and the prevalence 
of chimera strains. This may be due to morbidities which led to the need for residential 
care and/or related to the rest home environment. 
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Appendix IX: Abstract for University of Otago Student 
Research Symposium  
 
Oral Presentation, 4th August 2019 in, Dunedin, New Zealand 
 
First name:  Nurul 
Last name:  Thiyahuddin 
Campus:  Dunedin 
Email Address:  nurul.thiyahuddin@otago.ac.nz 
Type of presentation: Oral 
Name of Presenter:  Nurul Thiyahuddin 
Name of all authors and their departments:   
Prof Richard Cannon (SJWRI),  
Dr Erwin Lamping (SJWRI),  
Prof Alison Rich (SJWRI) 
Title of Presentation: Yeast Species in the Oral Cavities of Older People:  
A Comparison between People Living in Their Own Homes and Those in Rest Homes 
Keywords: oral candidiasis; older people; elderly; rest home; yeast carriage; Candida 
albicans 
 
Abstract:  Oral candidiasis is prevalent among older people due to predisposing 
factors such as impaired immune defenses, medications and denture use. An increasing 
number of older people live in rest home facilities and it is unclear how this 
institutionalized living affects the quantity and type of fungi colonizing these people’s 
oral cavities. Smears and swabs of the palate and tongue and saliva samples were taken 
from participants residing in rest homes (RH; n = 20) and older people living in their own 
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homes (OH; n = 20). Yeast in samples were quantified and identified by culturing on 
CHROMagar Candida and sequencing the ITS2 region of rDNA. A higher proportion of 
RH residents had hyphae present in smears compared to OH participants (35% vs. 30%) 
although this difference was not statistically significant (p = 0.74). RH residents had, on 
average, 23 times as many yeast per mL saliva as OH participants (p = 0.01). Seven yeast 
species were identified in OH samples and only five in RH samples, with Candida 
albicans and Candida glabrata being the most common species isolated from both 
participant groups. The results indicate that older people living in aged-care facilities 
were more likely to have candidiasis and have a higher yeast carriage rate than similarly 
aged people living at home. This may be due to morbidities which led to the need for 
residential care and/or related to the rest home environment. 
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Appendix X: FASTA file of all Candida albicans/Candida 
dubliniensis chimera strains  
 
The FASTA file below depicts the result of DNA sequencing using Multi Locus 
Sequence Typing of seven house keeping genes; H1-H7 for C. albicans/C. dubliniensis 
chimera strains ML3P1, MN2S4, MN2T4, MN2P1, MN5S1, MN5T1, MN5P1 and 
SL4T1). Each single nucleotide polymorphism (SNP) was colour coded blue (A or 
reference allele) and green (B or alternative allele). The colour turquoise indicates 
diploid sequence which appear as double peaks in the sequencing chromatogram.   
 
>ML3P1-H1 
TGATATTCCATTGGCTCCACCAGACAAAATTTTGGGTATTTCTGAAGCTTAT
AACAACGATTCTAACCCTCAAAAAATCAATTTGGGGGTTGGTGCTTATAGA
GATAATTCCGGTAAACCAATTATTTTCCCATCAGTTAAAAAAGCTGAAGAA
ATTTTATTGGGTAAAGAAACTGAAAAGGAATATACTGCCATTGTTGGTTCC
AAAAATTTCCAATCAATTGTGAAAAATTTCATTTTCAACAATTCTAATAAAG
ATGCCAATGGTAAACAATTAATTGATGATGGTAGAATTGTTACTGCTCAAA
CCATCTCTGGTACTGGATCACTTAGAGTTATCGCTGATTTCTTGAATYGTTT
CTATTCTAACAAGAAAATTTTGGTTCCAAAACCAACTTGGGCTAATCATGTT
GCTGTTTTCAAA 
>ML3P1-H2 – 1B:2A SNP ratio – aneuploid or triploid 
CATATTTTGAGGTCATCTGTTGTTCAAACCTCTTATGGTGAAATTTTTGCTA
AACATAGAGAACCAAATTTGGAAATTATTCGTGAGGTTGTTGATTCCAAAC
ATATTGTTTTTGATGTGTTGGCACAATTCTTAATCAATCCAGACCCATGGGT
TGCCATTGCTGCCGCTGAAGTTTATGTCAGACGTTCATACCGTGCTTATGAT
TTGGGTAMAATTGAATATCATGTTAATGACAGACTTCCTATTGTTGAATGG
AAATTCAAGTTGGCTAATATGGGAGCYGCTGGTGTAAACGATGCTCAACAG
GCTGCTGCTGCYGGTGGCGATGATTCGACATCTATGAAACATGCAGCTTCT
GTGTCTGATTTGACCTTTGTTGTTGATTCTAAAACCGAGCATTCCACAAGAA
CTGGTGTTTTAGCTCCAGCAAGACACTTGGATG 
>ML3P1-H3 
TCAGGTGAGTGTATTCATAAAAGCGAAATCCCAGGATACACTCTCCCCGAT
AATCCAAAGTTCACCCTTGGTAATTTGTTTGTAATAATTGGAGTCTTGTTGG
TTTGTRTTTTAGCTGTTGTCTCTCTTTTGAGAAATATTAGTGAGTCGGCCTTG
TTCAAGAAGAATGGGTATGAACCGTTGGATTCGGATCCTAGTGTCATGAAC
CTAAACTTCGAGCCTACAACATTGTCCTTTGAAGATATTAAATATGAGGTTA
CTGGTGGTCGACAAATTTTAAATGGAGTCTTTGGGTTTGTAAAACCAAGAG
AATGTTTGGCTATAATGGGAGGTTCAGGTGCTGGTAAAACTACATTGTTGG
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ATATTTTGGCTGGTAAGAACAAAGATGGTAAAATCGATGGATCAATTTATG
TGAACGGAAATCCAATAGACCCAAAACACTACAAGTCTATTATCGGGT 
>ML3P1-H4 – 1B:3A SNP ratio – aneuploid or tetraploid 
TTGGCTAARACTTTGRCYACTGTTCCTGAATTGAATGAAATTATTGGKCAAG
AWTTAGTTGACGAATTTGTCAGTGGTATTAAACTACCAGCAGAAGTTGGAA
GTCAAGATGATGTTAACAATAGAAAATTGTTGCAAAAAGTGTTTGGTAAAT
TAATGAACACTGATGATGACGTTATAAAACAACAAACAGCTAAATTACTTG
AAAGAACAGACAGAGAACCTCAAGTGTTCAAGGATATTGATTCTAGATTAC
CGGAGTTAATACAAAGATTAAACAAACAATTTCCTAATGACATCGGATTAT
TTTGTGGATGTCTCTTATTGAACCACGTTGGTTTGAACAAAGGGGAAGCAA
TGTTCTTACAAGCCAAAGATCCTCATGCTTATATTAGTGGTGATATAATTGA 
>ML3P1-H5 – ~1 part Candida dubliniensis and 3 parts Candida albicans 
>ML3P1-H6 
TGAGCTATACATGAAGCACCAAGGTGTTGTAGAGGATGCATCGAATTCAGA
AGAGTTTCAGTTTTCAAAGAATTTCAAAAAGAGGCTTTCACAATACGCTCC
GAGTGTACTTTCAACATATTCCGATGATTCTGATTATGAGGCTCCTCGAATT
CCAGAAGGTGTTGCTATTGTGAAAGGTGAAGAGATGAATGCCAATTTTGGT
GGTTTGAGATTTGTTTTGATTGGTGATGTATCAGAATTGCCTGTCCTTGATA
TGAAAATCAAACCTTTTGAAGCACGAGCAATTAACTGGTCCACGGATCTTA
ATGCTGAGGTACATATTGAGCATTATATAAATATATTCAATTATGCACGATC
ATCTTGGGAGCCATTGGTTGAAAGTTGGCCAATAGCAGTTTACATGTCAAA
ATCCCGACACCCAAAGCCTCAATTATTAGTAGAGGTGATTTCTAGACAGGT
AGCTCAAGTGACGCTTACATCCAAAGCGGTAGCATTGCTATCTCAAGTATC
CGATTTGATTACTTCCGGAGAAAAATTAAAACCAAGAGGTGAAGATTACCC
ATACGTTATAGTGAATGAGACTGGTTTAGATTTGGAAGTTTGGAATGATGC
AAATGAATCCGAAACCAAAACTGGAATCAAATCATGGGATTCTAAACCTTG
GAGCTTTGAGGACTG 
>ML3P1-H7 – mix of mostly Candida albicans and a bit Candida dubliniensis 
>MN2S4-H1 - Candida dubliniensis retrotransposon 
>MN2S4-H2 – Candida albicans 
CATATTTTGAGGTCATCTGTTGTTCAAACCTCTTATGGTGAAATTTTTGCTA
AACATAGAGAACCAAATTTGGAAATTATTCGTGAGGTTGTTGATTCCAAAC
ATATTGTTTTTGATGTGTTGGCACAATTCTTAATCAATCCAGACCCATGGGT
TGCCATTGCTGCCGCTGAAGTTTATGTCAGACGTTCATACCGTGCTTATGAT
TTGGGTAAAATTGAATATCATGTTAATGACAGACTTCCTATTGTTGAATGGA
AATTCAAGTTGGCTAATATGGGAGCCGCTGGTGTAAACGATGCTCAACAGG
CTGCTGCTGCCGGTGGCGATGATTCGACATCTATGAAACATGCAGCTTCTGT
GTCTGATTTGACCTTTGTTGTTGATTCTAAAACCGAGCATTCCACAAGAACT
GGTGTTTTAGCTCCAGCAAGACACTTGGATG 
>MN2S4-H3 – Candida dubliniensis 
TCAGGTGAGTGTATCCATAAAAGTGAAATACCAGGTTACACTATCCCAGAG
AATCCAAAGTTCACTCTTGGTAATTTGTTTGTGATAATTGGGGTCTTGTTGG
TTTGTGTTTTGGCAGTTGTCTCTCTCTTGAGAAATATTAGTGAGTCGGCCTT
GTTCAAGAAAAATGGGTATGAGCCATTGGATTCAGATCCTAGYGTCATGAA
TCAAAACTTTGAGCCTACAACATTGTCGTTTGAAGATATAAAGTATGAGGT
TGCTGGTGGTCGACAAATTTTGAATGGAGTCTTTGGGTTTGTAAAACCAAG
AGAATGYTTGGCAATAATGGGGGGTTCGGGTGCTGGTAAAACTACGTTATT
GGATATTTTGGCCGGTAAGAACAAGGATGGTATGATTAATGGATCGATTTA
TGTTAATGGAAATCCAATAGACCCAAAACATTACAGATCTATTATCGGGT 
>MN2S4-H4 – Candida dubliniensis 
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TTGGCTAAAACTTTGACTACAGTTCCTGAATTAAACGAAATTATTGGTCAAG
AATTGGTTGATGAATTTGTTAGTGGTATTAAACTACCAGCAGAAATTGGAA
GTCAAGATGATGTTAACAATAGAAAATTGTTACAAAAAGTGTTTGGTAAAT
TAATGAACACCAATGAAGATATTATAAAGCAACAAACTACTAAATTACTTG
AAAGAACAGAAAGGGAACCTCAAGTGTTTAAAAACATTGATTCTAGATTAC
CAGAGTTAATACAAAGATTGAACAAGCAATTTCCTAATGATATTGGATTAT
TTTGTGGATGTCTCTTGTTGAACCACGTTGGCTTGAACAAAGGGGAAGCAA
TGTTTTTACAAGCCAAAGACCCTCATGCATATATTAGTGGTGATATAATTGA 
>MN2S4-H5 – Candida dubliniensis 
TGAATTTGAACAAGAAATCGATGCTGCTGCAAGTTTACCATTTGGTGTTGTC
AAGGAATCTAAATCCAAGGAATTAGGGGTTGCGTTAAAGAAATTATCAATT
TCCGTATTGGATAAACAAAGATTAACTGAAAAATTCAATAAATTGGATAAA
TCAATCAAAGATAATTTGAAGGCTAGACAAAAAGAGGAAACCAAAAAGAC
ATTGGATGTAGTTAACAATTGGTTGAATGATAAAGAAAATGCTTCATCATTT
TTGGTTGCTCATGTTCCAATTACTGCTAATGCAAAGGCAATTACTGAAGCTA
TTAACTTGATCAAAAAGCAAGACAAATCTAAATCAATTTATTTGTTGACCG
GCGAAACCGATAAAGTTGCTCATGGATGTTATGTTAGTGATGAAGCTATTG
CCAAGGGAATTAATGCCAATGAGTTAGCTAAGGCTGTATCTGAAAACATTG
GTGGTAAAGCTGGTG 
>MN2S4-H6 – impossible to read sequence 
>MN2S4-H7 – Candida dubliniensis 
GCTTTTGATAATATTGATGTTAATGATGTTATATTGGGTCAATATACTAAAT
CAGAAGATGGTACTAAACCAGGTTATTTAGATGATAAAACGGTGAATCCTG
ATTCTAAAGCTGTTACTTATGCTGCTTTTAGAGTAAACATTCATAATGAAAG
ATGGGATGGTGTTCCAATTGTTTTACGTGCTGGTAAAGCTTTAGATGAAAGT
AAAGTTGAAATTAGAATTCAATTTAAACCTGTTGCTAAAGGAATGTTTAAA
GAAATTCAAAGAAATGAATTAGTTATTAGAATACAACCAAATGAAGCAATT
TATTTAAAAATTAATTCAAAAATCCCCGGGATTTCTACTGAAACTTCTTTAA
CTGATTTAGATTTAACTTATGCTACTCGTTATTCAAAAGATTTTTGGATTCC
AGAAGCTTATGAAGCTTTAATTAGAGATTGTTATTTAGGTAATCATTCTAAT
TTTGTTAGAGATGATGAATTGGATGTTTCTTGGAAATTATTTACTCCATTAT
TAAAAGCAGTTGAAGATCCTGCTAATAAAATAGAATTACAATATTATCCTT
ATGGTTCTAAAGGTCCAAAAGATTTAAGAAAATATTTGAAAGATCATGGTT
ATATATTTAGTGATCCAGGT 
>MN2T4-H1 - ~20% Candida dubliniensis retrotransposon 
TGATATTCCATTGGCCCCACCAGACAAGATTTTGGGTATTTCTGAAGCTTAT
AACAATGATTCTAACCCTCAAAAAATCAATTTGGGGGTTGGTGCTTATAGA
GATAATTCTGGTAAACCAATTATTTTCCCATCAGTTAAAAAAGCTGAAGAA
ATTTTATTGGGTAAAGAAACTGAAAAGGAATATACTGCCATTGTTGGTTCC
AAAAATTTCCAATCAATTGTGAAAAATTTCATTTTCAACAATTCTAATAAAG
ATGCCAATGGTAAACAATTAATTGATGATGGTAGAATTGTTACTGCTCAAA
CCATCTCTGGTACTGGATCACTTAGAGTTATTGCTGATTTTTTGAATCGTTTT
TATTCTAACAAGAAAATTTTGGTTCCAAAACCAACTTGGGCTAATCATGTTG
CTGTTTTCAAA 
>MN2T4-H2 – Candida albicans 
CATATTTTGAGGTCATCTGTTGTTCAAACCTCTTATGGTGAAATTTTTGCTA
AACATAGAGAACCAAATTTGGAAATTATTCGTGAGGTTGTTGATTCCAAAC
ATATTGTTTTTGATGTGTTGGCACAATTCTTAATCAATCCAGACCCATGGGT
TGCCATTGCTGCCGCTGAAGTTTATGTCAGACGTTCATACCGTGCTTATGAT
TTGGGTAAAATTGAATATCATGTTAATGACAGACTTCCTATTGTTGAATGGA
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AATTCAAGTTGGCTAATATGGGAGCCGCTGGTGTAAACGATGCTCAACAGG
CTGCTGCTGCCGGTGGCGATGATTCGACATCTATGAAACATGCAGCTTCTGT
GTCTGATTTGACCTTTGTTGTTGATTCTAAAACCGAGCATTCCACAAGAACT
GGTGTTTTAGCTCCAGCAAGACACTTGGATG 
>MN2T4-H2 – a second experiment amplified 2 parts Candida albicans and 1 part 
Candida dubliniensis  
CATATTTTGAGRTCATCTGTTGTTCAAACCTCKTATGGTGAAATTTTTGCTA
AACATAGAGAACCAAATTTGGAAATTATTCGTGARGTTGTTGATTCCAAAC
AYATTGTTTTTGATGTGTTGKCACAATTYTTRATCAATCCAGAYCCATGGGT
TGCCATTGCTGCMGCTGAAGTKTATGTCAGACGTTCATACCGTGCTTATGAT
TTGGGTAAAATTGAATATCATGTTAAYGACAGACTTCCTATTGTTGAATGG
AAATTCAAGTTRGCTARTATGGGAGCCGCTGGWGTAAAYGATGCTCAACA
GGCTGCTGCTGCYGGTGGYGATGAYTCRACATCWATGAAACATGCWGCTT
CWGTKTCTGATTTGACCTTTGTTGTTGATTCYAAAACCGAGCATWCYACAA
GAACTGGTGTKTTAGCTCCMGCAAGACACTTGGATG 
>MN2T4-H3 – Candida dubliniensis 
TCAGGTGAGTGTATCCATAAAAGTGAAATACCAGGTTACACTATCCCAGAG
AATCCAAAGTTCACTCTTGGTAATTTGTTTGTGATAATTGGGGTCTTGTTGG
TTTGTGTTTTGGCAGTTGTCTCTCTCTTGAGAAATATTAGTGAGTCGGCCTT
GTTCAAGAAAAATGGGTATGAGCCATTGGATTCAGATCCTAGYGTCATGAA
TCAAAACTTTGAGCCTACAACATTGTCGTTTGAAGATATAAAGTATGAGGT
TGCTGGTGGTCGACAAATTTTGAATGGAGTCTTTGGGTTTGTAAAACCAAG
AGAATGYTTGGCAATAATGGGGGGTTCGGGTGCTGGTAAAACTACGTTATT
GGATATTTTGGCCGGTAAGAACAAGGATGGTATGATTAATGGATCGATTTA
TGTTAATGGAAATCCAATAGACCCAAAACATTACAGATCTATTATCGGGT 
>MN2T4-H4 - Candida dubliniensis – 2nd experiment also amplified ~10% Candida 
albicans 
TTGGCTAAAACTTTGACTACAGTTCCTGAATTAAACGAAATTATTGGTCAAG
AATTGGTTGATGAATTTGTTAGTGGTATTAAACTACCAGCAGAAATTGGAA
GTCAAGATGATGTTAACAATAGAAAATTGTTACAAAAAGTGTTTGGTAAAT
TAATGAACACCAATGAAGATATTATAAAGCAACAAACTACTAAATTACTTG
AAAGAACAGAAAGGGAACCTCAAGTGTTTAAAAACATTGATTCTAGATTAC
CAGAGTTAATACAAAGATTGAACAAGCAATTTCCTAATGATATTGGATTAT
TTTGTGGATGTCTCTTGTTGAACCACGTTGGCTTGAACAAAGGGGAAGCAA
TGTTTTTACAAGCCAAAGACCCTCATGCATATATTAGTGGTGATATAATTGA 
>MN2T4-H5 – Candida dubliniensis 
TGAATTTGAACAAGAAATCGATGCTGCTGCAAGTTTACCATTTGGTGTTGTC
AAGGAATCTAAATCCAAGGAATTAGGGGTTGCGTTAAAGAAATTATCAATT
TCCGTATTGGATAAACAAAGATTAACTGAAAAATTCAATAAATTGGATAAA
TCAATCAAAGATAATTTGAAGGCTAGACAAAAAGAGGAAACCAAAAAGAC
ATTGGATGTAGTTAACAATTGGTTGAATGATAAAGAAAATGCTTCATCATTT
TTGGTTGCTCATGTTCCAATTACTGCTAATGCAAAGGCAATTACTGAAGCTA
TTAACTTGATCAAAAAGCAAGACAAATCTAAATCAATTTATTTGTTGACCG
GCGAAACCGATAAAGTTGCTCATGGATGTTATGTTAGTGATGAAGCTATTG
CCAAGGGAATTAATGCCAATGAGTTAGCTAAGGCTGTATCTGAAAACATTG
GTGGTAAAGCTGGTG 
>MN2T4-H6 – Candida dubliniensis ~20% bad background sequence  
CGACTTGTACATGAAGTACCAAGGTATGGTTGAAGACACATCAAATTCAGA
AGAATTCCAGTTCTCGAAGAATTTCAAAAAGAGGCTTTCGCAGTATGCTCC
TAGTGTGCTTTCAACATATTCTGATGAATCCGATTATGAGACTCCCCGAATT
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CCACCAGGTGTTGCTATTGTAAAAGGTGAAGAGTTGAATGCCAATTTTGGT
GGTTTGAGATTTGTTTTGATTGGTGATGTATCTGAGTTGCCTGTCCTTGATAT
GCAAATCAAACCTTTTGAAGCACGGGCAATCAACTGGTCCACAGATCTTAA
TGCTGAAGTTCATATTGAGCATTATATCAATATTTTCAATTATGCACGATCG
TCTTGGGAACCTTTGGTTGAAAGCTGGCCAATAGCAGTTTACATGTCAAAA
GCTCGACACCCGAAACCTCAATTATTAGTGGAAATAATTTCCAGACAAGTA
GCTCAAGTGACGCTTACATCTAAGGCAGTAGCATTGTTATCACAAGTATCT
GATTTGATTACTTCTGGAGAGAAATTGAAACCAAGAGGTGAAGATTATCCA
TATGTAATAGTAAATGAAACTGGATTAGATTTGGAAGTTTGGAATGATACA
AAGGAATCCGAAACTAGAACCGAAATAAAATCTTGGGACTCTAAACCTTGG
AGTTTTGAG 
>MN2T4-H6 – 2nd experiment amplified a Candida albicans allele 
TGAGCTATACATGAAGCACCAAGGTGTTGTAGAGGATACATCGAATTCAGA
AGAGTTTCAGTTTTCAAAGAATTTCAAAAAGAGGCTTTCACAATACGCTCC
GAGTGTACTTTCAACATATTCCGATGATTCTGATTATGAGGCTCCTCGAATT
CCAGAAGGTGTTGCTATTGTGAAAGGTGAAGAGATGAATGCCAATTTTGGT
GGTTTGAGATTTGTTTTGATTGGTGATGTATCAGAATTGCCTGTCCTTGATA
TGAAAATCAAACCTTTTGAAGCACGAGCAATTAACTGGTCCACGGATCTTA
ATGCTGAGGTACATATTGAGCATTATATAAATATATTCAATTATGCACGATC
ATCTTGGGAGCCATTGGTTGAAAGTTGGCCAATAGCAGTTTACATGTCAAA
ATCCCGACACCCAAAGCCTCAATTATTAGTAGAGGTGATTTCTAGACAGGT
AGCTCAAGTGACGCTTACATCCAAAGCAGTAGCATTGCTATCTCAAGTATC
CGATTTGATTACTTCCAGAGAAAAATTAAAACCAAGAGGTGAAGATTACCC
ATACGTTATAATGAATGAGACTGGTTTAGATTTGGAAGTTTGGAATGATGC
AAATGAATCCGAAACCAAAACTGGAATCAAATCATGGGATTCTAAACCTTG
GAGCTTTGAGGACTG 
>MN2T4-H7 – Candida dubliniensis 
GCTTTTGATAATATTGATGTTAATGATGTTATATTGGGTCAATATACTAAAT
CAGAAGATGGTACTAAACCAGGTTATTTAGATGATAAAACGGTGAATCCTG
ATTCTAAAGCTGTTACTTATGCTGCTTTTAGAGTAAACATTCATAATGAAAG
ATGGGATGGTGTTCCAATTGTTTTACGTGCTGGTAAAGCTTTAGATGAAAGT
AAAGTTGAAATTAGAATTCAATTTAAACCTGTTGCTAAAGGAATGTTTAAA
GAAATTCAAAGAAATGAATTAGTTATTAGAATACAACCAAATGAAGCAATT
TATTTAAAAATTAATTCAAAAATCCCCGGGATTTCTACTGAAACTTCTTTAA
CTGATTTAGATTTAACTTATGCTACTCGTTATTCAAAAGATTTTTGGATTCC
AGAAGCTTATGAAGCTTTAATTAGAGATTGTTATTTAGGTAATCATTCTAAT
TTTGTTAGAGATGATGAATTGGATGTTTCTTGGAAATTATTTACTCCATTAT
TAAAAGCAGTTGAAGATCCTGCTAATAAAATAGAATTACAATATTATCCTT
ATGGTTCTAAAGGTCCAAAAGATTTAAGAAAATATTTGAAAGATCATGGTT
ATATATTTAGTGATCCAGGT 
>MN2P1-H1 - ~20% Candida dubliniensis retrotransposon 
TGATATTCCATTGGCCCCACCAGACAAGATTTTGGGTATTTCTGAAGCTTAT
AACAATGATTCTAACCCTCAAAAAATCAATTTGGGGGTTGGTGCTTATAGA
GATAATTCTGGTAAACCAATTATTTTCCCATCAGTTAAAAAAGCTGAAGAA
ATTTTATTGGGTAAAGAAACTGAAAAGGAATATACTGCCATTGTTGGTTCC
AAAAATTTCCAATCAATTGTGAAAAATTTCATTTTCAACAATTCTAATAAAG
ATGCCAATGGTAAACAATTAATTGATGATGGTAGAATTGTTACTGCTCAAA
CCATCTCTGGTACTGGATCACTTAGAGTTATTGCTGATTTTTTGAATCGTTTT
TATTCTAACAAGAAAATTTTGGTTCCAAAACCAACTTGGGCTAATCATGTTG
CTGTTTTCAAA 
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>MN2P1-H2 – Candida albicans 
CATATTTTGAGGTCATCTGTTGTTCAAACCTCTTATGGTGAAATTTTTGCTA
AACATAGAGAACCAAATTTGGAAATTATTCGTGAGGTTGTTGATTCCAAAC
ATATTGTTTTTGATGTGTTGGCACAATTCTTAATCAATCCAGACCCATGGGT
TGCCATTGCTGCCGCTGAAGTTTATGTCAGACGTTCATACCGTGCTTATGAT
TTGGGTAAAATTGAATATCATGTTAATGACAGACTTCCTATTGTTGAATGGA
AATTCAAGTTGGCTAATATGGGAGCCGCTGGTGTAAACGATGCTCAACAGG
CTGCTGCTGCCGGTGGCGATGATTCGACATCTATGAAACATGCAGCTTCTGT
GTCTGATTTGACCTTTGTTGTTGATTCTAAAACCGAGCATTCCACAAGAACT
GGTGTTTTAGCTCCAGCAAGACACTTGGATG 
>MN2P1-H3 - Candida dubliniensis 
TCAGGTGAGTGTATCCATAAAAGTGAAATACCAGGTTACACTATCCCAGAG
AATCCAAAGTTCACTCTTGGTAATTTGTTTGTGATAATTGGGGTCTTGTTGG
TTTGTGTTTTGGCAGTTGTCTCTCTCTTGAGAAATATTAGTGAGTCGGCCTT
GTTCAAGAAAAATGGGTATGAGCCATTGGATTCAGATCCTAGYGTCATGAA
TCAAAACTTTGAGCCTACAACATTGTCGTTTGAAGATATAAAGTATGAGGT
TGCTGGTGGTCGACAAATTTTGAATGGAGTCTTTGGGTTTGTAAAACCAAG
AGAATGYTTGGCAATAATGGGGGGTTCGGGTGCTGGTAAAACTACGTTATT
GGATATTTTGGCCGGTAAGAACAAGGATGGTATGATTAATGGATCGATTTA
TGTTAATGGAAATCCAATAGACCCAAAACATTACAGATCTATTATCGGGT 
>MN2P1-H4 - Candida dubliniensis and ~10% Candida albicans 
TTGGCTAAAACTTTGACTACAGTTCCTGAATTAAACGAAATTATTGGTCAAG
AATTGGTTGATGAATTTGTTAGTGGTATTAAACTACCAGCAGAAATTGGAA
GTCAAGATGATGTTAACAATAGAAAATTGTTACAAAAAGTGTTTGGTAAAT
TAATGAACACCAATGAAGATATTATAAAGCAACAAACTACTAAATTACTTG
AAAGAACAGAAAGGGAACCTCAAGTGTTTAAAAACATTGATTCTAGATTAC
CAGAGTTAATACAAAGATTGAACAAGCAATTTCCTAATGATATTGGATTAT
TTTGTGGATGTCTCTTGTTGAACCACGTTGGCTTGAACAAAGGGGAAGCAA
TGTTTTTACAAGCCAAAGACCCTCATGCATATATTAGTGGTGATATAATTGA 
>MN2P1-H5 – Candida dubliniensis 
TGAATTTGAACAAGAAATCGATGCTGCTGCAAGTTTACCATTTGGTGTTGTC
AAGGAATCTAAATCCAAGGAATTAGGGGTTGCGTTAAAGAAATTATCAATT
TCCGTATTGGATAAACAAAGATTAACTGAAAAATTCAATAAATTGGATAAA
TCAATCAAAGATAATTTGAAGGCTAGACAAAAAGAGGAAACCAAAAAGAC
ATTGGATGTAGTTAACAATTGGTTGAATGATAAAGAAAATGCTTCATCATTT
TTGGTTGCTCATGTTCCAATTACTGCTAATGCAAAGGCAATTACTGAAGCTA
TTAACTTGATCAAAAAGCAAGACAAATCTAAATCAATTTATTTGTTGACCG
GCGAAACCGATAAAGTTGCTCATGGATGTTATGTTAGTGATGAAGCTATTG
CCAAGGGAATTAATGCCAATGAGTTAGCTAAGGCTGTATCTGAAAACATTG
GTGGTAAAGCTGGTG 
>MN2P1-H6 – mix of H6 and Candida dubliniensis cell wall mannoprotein  
>MN2P1-H7 – Candida dubliniensis 
GCTTTTGATAATATTGATGTTAATGATGTTATATTGGGTCAATATACTAAAT
CAGAAGATGGTACTAAACCAGGTTATTTAGATGATAAAACGGTGAATCCTG
ATTCTAAAGCTGTTACTTATGCTGCTTTTAGAGTAAACATTCATAATGAAAG
ATGGGATGGTGTTCCAATTGTTTTACGTGCTGGTAAAGCTTTAGATGAAAGT
AAAGTTGAAATTAGAATTCAATTTAAACCTGTTGCTAAAGGAATGTTTAAA
GAAATTCAAAGAAATGAATTAGTTATTAGAATACAACCAAATGAAGCAATT
TATTTAAAAATTAATTCAAAAATCCCCGGGATTTCTACTGAAACTTCTTTAA
CTGATTTAGATTTAACTTATGCTACTCGTTATTCAAAAGATTTTTGGATTCC
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AGAAGCTTATGAAGCTTTAATTAGAGATTGTTATTTAGGTAATCATTCTAAT
TTTGTTAGAGATGATGAATTGGATGTTTCTTGGAAATTATTTACTCCATTAT
TAAAAGCAGTTGAAGATCCTGCTAATAAAATAGAATTACAATATTATCCTT
ATGGTTCTAAAGGTCCAAAAGATTTAAGAAAATATTTGAAAGATCATGGTT
ATATATTTAGTGATCCAGGT 
>MN5S1-H1 - mix of Candida albicans H1 and Candida dubliniensis retrotransposon  
>MN5S1-H2 - 1:1 SNP ratios for C albicans and C dubliniensis 
CATATTTTGAGRTCATCTGTTGTTCAAACCTCKTATGGTGAAATTTTTGCTA
AACATAGAGAACCAAATTTGGAAATTATTCGTGARGTTGTTGATTCCAAAC
AYATTGTTTTTGATGTGTTGKCACAATTYTTRATCAATCCAGAYCCATGGGT
TGCCATTGCTGCMGCTGAAGTKTATGTCAGACGTTCATACCGTGCTTATGAT
TTGGGTAAAATTGAATATCATGTTAAYGACAGACTTCCTATTGTTGAATGG
AAATTCAAGTTRGCTARTATGGGAGCCGCTGGWGTAAAYGATGCTCAACA
GGCTGCTGYTGCYGGTGGYGATGAYTCRACATCWATGAAACATGCWGCTT
CWGTKTCTGATTTGACCTTTGTTGTTGATTCYAAAACCGAGCATWCYACAA
GAACTGGTGTKTTAGCTCCMGCAAGACACTTGGATG 
>MN5S1-H3 – Candida dubliniensis 
TCAGGTGAGTGTATCCATAAAAGTGAAATACCAGGTTACACTATCCCAGAG
AATCCAAAGTTCACTCTTGGTAATTTGTTTGTGATAATTGGGGTCTTGTTGG
TTTGTGTTTTGGCAGTTGTCTCTCTCTTGAGAAATATTAGTGAGTCGGCCTT
GTTCAAGAAAAATGGGTATGAGCCATTGGATTCAGATCCTAGCGTCATGAA
TCAAAACTTTGAGCCTACAACATTGTCGTTTGAAGATATAAAGTATGAGGT
TGCTGGTGGTCGACAAATTTTGAATGGAGTCTTTGGGTTTGTAAAACCAAG
AGAATGTTTGGCAATAATGGGGGGTTCGGGTGCTGGTAAAACTACGTTATT
GGATATTTTGGCCGGTAAGAACAAGGATGGTATGATTAATGGATCGATTTA
TGTTAATGGAAATCCAATAGACCCAAAACATTACAGATCTATTATCGGGT 
>MN5S1-H4 - Candida dubliniensis 
TTGGCTAAAACTTTGACTACAGTTCCTGAATTAAACGAAATTATTGGTCAAG
AATTGGTTGATGAATTTGTTAGTGGTATTARACTACCAGCAGAAATTGGAA
GTCAAGATGATGTTAACAATAGAAAATTGTTACAAAAAGTGTTTGGTAAAT
TAATGAACACCAATGAAGATATTATAAAGCAACAAACTACTAAATTACTTG
AAAGAACAGAAAGGGAACCTCAAGTGTTTAAAAACATTGATTCTAGATTAC
CAGAGTTAATACAAAGATTGAACAAGCAATTTCCTAATGATATTGGATTAT
TTTGTGGATGTCTCTTGTTGAACCACGTTGGCTTGAACAAAGGGGAAGCRA
TGTTTTTACAAGCCAAAGACCCTCATGCATATATTAGTGGTGATATAATTGA 
>MN5S1-H5 - Candida dubliniensis 
TGAATTTGAACAAGAAATCGATGCTGCTGCAAGTTTACCATTTGGTGTTGTC
AAGGAATCTAAATCCAAGGAATTAGGGGTTGCGTTAAAGAAATTATCAATT
TCCGTATTGGATAAACAAAGATTAACTGAAAAATTCAACAAATTGGATAAA
TCAATCAAAGATAATTTGAAGGCTAGACAAAAAGAGGAAACCAAAAAGAC
ATTAGATGTAGTTAACAATTGGTTGAATGATAAAGAAAATGTTTCATCATTT
TTGGTTTCTCATGTTCCAATTACTGCTAATGCAAAGGCAATTACTGAAGCTA
TTAACTTGATCAAAAAGCAAGACAAATCTAAATCAATTTATTTGTTGACCG
GCGAAACCGATAAAGTTGCTCATGGATGTTATGTTAGTGATGAAGCTATTG
CCAAGGGAATTAATGCCAATGAGTTAGCTAAGGCTGTATCTGAAAACATTG
GTGGTAAAGCTGGTG 
>MN5S1-H6 - three of six have 1:2 SNP ratio – tri- or tetraploid 
TGAGCTATACATGAAGCACCAAGGTGTTGTAGAGGATRCATCGAATTCAGA
AGAGTTTCAGTTTTCAAAGAATTTCAAAAAGAGGCTTTCACAATACGCTCC
GAGTGTACTTTCAACATATTCCGATGATTCTGATTATGAGRCTCCTCGAATT
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CCAGAAGGTGTTGCTATTGTGAAAGGTGAAGAGATGAATGCCAATTTTGGT
GGTTTGAGRTTTGTTTTGATTGGTGATGTATCAGAATTGCCTGTCCTTGATA
TGAAAATCAAACCTTTTGAAGCACGAGCAATTAACTGGTCCACGGATCTTA
ATGCTGAGGTACATATTGAGCATTATATAAATATATTCAATTATGCACGATC
ATCTTGGGAGCCATTGGTTGAAAGTTGGCCAATAGCAGTTTACATGTCAAA
ATCCCGACACCCAAAGCCTCAATTATTAGTAGAGGTGATTTCTAGACAGGT
AGCTCAAGTGACGCTTACATCCAAAGCRGTAGCATTGCTATCTCAAGTATC
CGATTTGATTACTTCCGGAGAAAAATTAAAACCAAGAGGTGAAGATTACCC
ATACRTTATAGTGAATGAGACTGGTTTAGATTTGGAAGTTTGGAATGATGC
AAAWGAATCCGAAACCAAAACTGGAATCAAATCATGGGATTCTAAACCTT
GGAGCTTTGAGGACTG 
>MN5S1-H7 – Candida dubliniensis 
GCTTTTGATAATATTGATGTTAATGATGTTATATTGGGTCAATATACTAAAT
CAGAAGATGGTACCAAACCAGGTTATTTAGATGATAAAACGGTGAATCCTG
ATTCTAAAGCTGTTACTTATGCTGCTTTTAGAGTAAACATTCATAATGAAAG
ATGGGATGGTGTTCCAATTGTTTTACGTGCTGGTAAAGCTTTAGATGAAAGT
AAAGTTGAAATTAGAATTCAATTTAAACCTGTTGCTAAAGGAATGTTTAAA
GAAATTCAAAGAAATGAATTAGTTATTAGAATACAACCAAATGAAGCAATT
TATTTAAAAATTAATTCAAAGATCCCCGGGATTTCTACTGAAACTTCTTTAA
CTGATTTAGATTTAACTTATGCTACTCGTTATTCAAAAGATTTTTGGATTCC
AGAAGCTTATGAAGCTTTAATTAGAGATTGTTATTTAGGTAATCATTCTAAT
TTTGTTAGAGATGATGAATTGGATGTTTCTTGGAAATTATTTACTCCATTAT
TAAAAGCAGTTGAAGATCCTGCTAATAAAATAGAATTACAATATTATCCTT
ATGGTTCAAAAGGTCCAAAAGATTTAAGAAAATATTTGAAAGATCATGGTT
ATATATTTAGTGATCCAGGT 
>MN5T1-H1 - mix of Candida albicans H1 and Candida dubliniensis retrotransposon  
>MN5T1-H2 - 2:1 SNP ratios for C albicans and C dubliniensis 
CATATTTTGAGRTCATCTGTTGTTCAAACCTCKTATGGTGAAATTTTTGCTA
AACATAGAGAACCAAATTTGGAAATTATTCGTGARGTTGTTGATTCCAAAC
AYATTGTTTTTGATGTGTTGKCACAATTYTTRATCAATCCAGAYCCATGGGT
TGCCATTGCTGCMGCTGAAGTKTATGTCAGACGTTCATACCGTGCTTATGAT
TTGGGTAAAATTGAATATCATGTTAAYGACAGACTTCCTATTGTTGAATGG
AAATTCAAGTTRGCTARTATGGGAGCCGCTGGWGTAAAYGATGCTCAACA
GGCTGCTGYTGCYGGTGGYGATGAYTCRACATCWATGAAACATGCWGCTT
CWGTKTCTGATTTGACCTTTGTTGTTGATTCYAAAACCGAGCATWCYACAA
GAACTGGTGTKTTAGCTCCMGCAAGACACTTGGATG 
>MN5T1-H3 – Candida dubliniensis 
TCAGGTGAGTGTATCCATAAAAGTGAAATACCAGGTTACACTATCCCAGAG
AATCCAAAGTTCACTCTTGGTAATTTGTTTGTGATAATTGGGGTCTTGTTGG
TTTGTGTTTTGGCAGTTGTCTCTCTCTTGAGAAATATTAGTGAGTCGGCCTT
GTTCAAGAAAAATGGGTATGAGCCATTGGATTCAGATCCTAGCGTCATGAA
TCAAAACTTTGAGCCTACAACATTGTCGTTTGAAGATATAAAGTATGAGGT
TGCTGGTGGTCGACAAATTTTGAATGGAGTCTTTGGGTTTGTAAAACCAAG
AGAATGTTTGGCAATAATGGGGGGTTCGGGTGCTGGTAAAACTACGTTATT
GGATATTTTGGCCGGTAAGAACAAGGATGGTATGATTAATGGATCGATTTA
TGTTAATGGAAATCCAATAGACCCAAAACATTACAGATCTATTATCGGGT 
>MN5T1-H4 - Candida dubliniensis 
TTGGCTAAAACTTTGACTACAGTTCCTGAATTAAACGAAATTATTGGTCAAG
AATTGGTTGATGAATTTGTTAGTGGTATTARACTACCAGCAGAAATTGGAA
GTCAAGATGATGTTAACAATAGAAAATTGTTACAAAAAGTGTTTGGTAAAT
 143 
TAATGAACACCAATGAAGATATTATAAAGCAACAAACTACTAAATTACTTG
AAAGAACAGAAAGGGAACCTCAAGTGTTTAAAAACATTGATTCTAGATTAC
CAGAGTTAATACAAAGATTGAACAAGCAATTTCCTAATGATATTGGATTAT
TTTGTGGATGTCTCTTGTTGAACCACGTTGGCTTGAACAAAGGGGAAGCRA
TGTTTTTACAAGCCAAAGACCCTCATGCATATATTAGTGGTGATATAATTGA 
>MN5T1-H5 - Candida dubliniensis and ~10% Candida albicans 
TGAATTTGAACAAGAAATCGATGCTGCTGCAAGTTTACCATTTGGTGTTGTC
AAGGAATCTAAATCCAAGGAATTAGGGGTTGCGTTAAAGAAATTATCAATT
TCCGTATTGGATAAACAAAGATTAACTGAAAAATTCAACAAATTGGATAAA
TCAATCAAAGATAATTTGAAGGCTAGACAAAAAGAGGAAACCAAAAAGAC
ATTAGATGTAGTTAACAATTGGTTGAATGATAAAGAAAATGTTTCATCATTT
TTGGTTTCTCATGTTCCAATTACTGCTAATGCAAAGGCAATTACTGAAGCTA
TTAACTTGATCAAAAAGCAAGACAAATCTAAATCAATTTATTTGTTGACCG
GCGAAACCGATAAAGTTGCTCATGGATGTTATGTTAGTGATGAAGCTATTG
CCAAGGGAATTAATGCCAATGAGTTAGCTAAGGCTGTATCTGAAAACATTG
GTGGTAAAGCTGGTG 
>MN5T1-H6 – three unique SNPs all in the 1st position have ~1:2 ratios with the 
typical SNP twice as high – tri or tetraploid 
TGAGCTATACATGAAGCACCAAGGTGTTGTAGAGGATACATCGAATTCAGA
AGAGTTTCAGTTTTCAAAGAATTTCAAAAAGAGGCTTTCACAAYACGCTCC
GAGTGTACTTTCAACATATTCCGATGATTCTGATTATGAGGCTCCTCGAATT
CCAGAAGGTGTTGCTATTGTGAAAGGTRAAGAGATGAATGCCAATTTTGGT
GGTTTGAGATTTGTTTTGATTGGTGATGTATCAGAATTGCCTGTCCTTGATA
TGAAAATCAAACCTTTTGAAGCACGAGCAATTAACTGGTCCACGGATCTTA
ATGCTGAGGTACATATTGAGCATTATATARATATATTCAATTATGCACGATC
ATCTTGGGAGCCATTGGTTGAAAGTTGGCCAATAGCAGTTTACATGTCAAA
ATCCCGACACCCAAAGCCTCAATTATTAGTAGAGGTGATTTCTAGACAGGT
AGCTCAAGTGACGCTTACATCCAAAGCAGTAGCATTGCTATCTCAAGTATC
CGATTTGATTACTTCCAGAGAAAAATTAAAACCAAGAGGTGAAGATTACCC
ATACGTGATAGTGAATGAGACTGGTTTAGATTTGGAAGTTTGGAATGATGC
AAATGAATTCGAAACCAAAACTGGAATCAAATCATGGGATTCTAAACCTTG
GAGCTTTGAGGACTG 
>MN5T1-H7 – Candida dubliniensis 
GCTTTTGATAATATTGATGTTAATGATGTTATATTGGGTCAATATACTAAAT
CAGAAGATGGTACCAAACCAGGTTATTTAGATGATAAAACGGTGAATCCTG
ATTCTAAAGCTGTTACTTATGCTGCTTTTAGAGTAAACATTCATAATGAAAG
ATGGGATGGTGTTCCAATTGTTTTACGTGCTGGTAAAGCTTTAGATGAAAGT
AAAGTTGAAATTAGAATTCAATTTAAACCTGTTGCTAAAGGAATGTTTAAA
GAAATTCAAAGAAATGAATTAGTTATTAGAATACAACCAAATGAAGCAATT
TATTTAAAAATTAATTCAAAGATCCCCGGGATTTCTACTGAAACTTCTTTAA
CTGATTTAGATTTAACTTATGCTACTCGTTATTCAAAAGATTTTTGGATTCC
AGAAGCTTATGAAGCTTTAATTAGAGATTGTTATTTAGGTAATCATTCTAAT
TTTGTTAGAGATGATGAATTGGATGTTTCTTGGAAATTATTTACTCCATTAT
TAAAAGCAGTTGAAGATCCTGCTAATAAAATAGAATTACAATATTATCCTT
ATGGTTCAAAAGGTCCAAAAGATTTAAGAAAATATTTGAAAGATCATGGTT
ATATATTTAGTGATCCAGGT 
>MN5P1-H1 - ~20% Candida dubliniensis retrotransposon 
TGATATTCCATTGGCYCCACCAGACAARATTTTGGGTATTTCTGAAGCTTAT
AACAATGATTCTAACCCTCAAAAAATCAATTTGGGGGTTGGTGCTTATAGA
GATAATTCYGGTAAACCAATTATTTTCCCATCAGTTAAAAAAGCTGAAGAA
 144 
ATTTTATTGGGTAAAGAAACTGAAAAGGAATATACTGCCATTGTTGGTTCC
AAAAATTTCCAATCAATTGTGAAAAATTTCATTTTCAACAATTCTAATAAAG
ATGCCAATGGTAAACAATTAATTGATGATGGTAGAATTGTTACTGCTCAAA
CCATCTCTGGTACTGGATCACTTAGAGTTATYGCTGATTTYTTGAATCGTTT
YTATTCTAACAAGAAAATTTTGGTTCCAAAACCAACTTGGGCTAATCATGTT
GCTGTTTTCAAA  
>MN5P1-H2 - 2:1 SNP ratios for C albicans and C dubliniensis 
CATATTTTGAGRTCATCTGTTGTTCAAACCTCKTATGGTGAAATTTTTGCTA
AACATAGAGAACCAAATTTGGAAATTATTCGTGARGTTGTTGATTCCAAAC
AYATTGTTTTTGATGTGTTGKCACAATTYTTRATCAATCCAGAYCCATGGGT
TGCCATTGCTGCMGCTGAAGTKTATGTCAGACGTTCATACCGTGCTTATGAT
TTGGGTAAAATTGAATATCATGTTAAYGACAGACTTCCTATTGTTGAATGG
AAATTCAAGTTRGCTARTATGGGAGCCGCTGGWGTAAAYGATGCTCAACA
GGCTGCTGYTGCYGGTGGYGATGAYTCRACATCWATGAAACATGCWGCTT
CWGTKTCTGATTTGACCTTTGTTGTTGATTCYAAAACCGAGCATWCYACAA
GAACTGGTGTKTTAGCTCCMGCAAGACACTTGGATG 
>MN5P1-H3 – Candida dubliniensis 
TCAGGTGAGTGTATCCATAAAAGTGAAATACCAGGTTACACTATCCCAGAG
AATCCAAAGTTCACTCTTGGTAATTTGTTTGTGATAATTGGGGTCTTGTTGG
TTTGTGTTTTGGCAGTTGTCTCTCTCTTGAGAAATATTAGTGAGTCGGCCTT
GTTCAAGAAAAATGGGTATGAGCCATTGGATTCAGATCCTAGCGTCATGAA
TCAAAACTTTGAGCCTACAACATTGTCGTTTGAAGATATAAAGTATGAGGT
TGCTGGTGGTCGACAAATTTTGAATGGAGTCTTTGGGTTTGTAAAACCAAG
AGAATGTTTGGCAATAATGGGGGGTTCGGGTGCTGGTAAAACTACGTTATT
GGATATTTTGGCCGGTAAGAACAAGGATGGTATGATTAATGGATCGATTTA
TGTTAATGGAAATCCAATAGACCCAAAACATTACAGATCTATTATCGGGT 
>MN5P1-H4 - Candida dubliniensis 
TTGGCTAAAACTTTGACTACAGTTCCTGAATTAAACGAAATTATTGGTCAAG
AATTGGTTGATGAATTTGTTAGTGGTATTARACTACCAGCAGAAATTGGAA
GTCAAGATGATGTTAACAATAGAAAATTGTTACAAAAAGTGTTTGGTAAAT
TAATGAACACCAATGAAGATATTATAAAGCAACAAACTACTAAATTACTTG
AAAGAACAGAAAGGGAACCTCAAGTGTTTAAAAACATTGATTCTAGATTAC
CAGAGTTAATACAAAGATTGAACAAGCAATTTCCTAATGATATTGGATTAT
TTTGTGGATGTCTCTTGTTGAACCACGTTGGCTTGAACAAAGGGGAAGCRA
TGTTTTTACAAGCCAAAGACCCTCATGCATATATTAGTGGTGATATAATTGA 
>MN5P1-H5 - Candida dubliniensis and ~15% Candida albicans 
TGAATTTGAACAAGAAATCGATGCTGCTGCAAGTTTACCATTTGGTGTTGTC
AAGGAATCTAAATCCAAGGAATTAGGGGTTGCGTTAAAGAAATTATCAATT
TCCGTATTGGATAAACAAAGATTAACTGAAAAATTCAACAAATTGGATAAA
TCAATCAAAGATAATTTGAAGGCTAGACAAAAAGAGGAAACCAAAAAGAC
ATTAGATGTAGTTAACAATTGGTTGAATGATAAAGAAAATGTTTCATCATTT
TTGGTTTCTCATGTTCCAATTACTGCTAATGCAAAGGCAATTACTGAAGCTA
TTAACTTGATCAAAAAGCAAGACAAATCTAAATCAATTTATTTGTTGACCG
GCGAAACCGATAAAGTTGCTCATGGATGTTATGTTAGTGATGAAGCTATTG
CCAAGGGAATTAATGCCAATGAGTTAGCTAAGGCTGTATCTGAAAACATTG
GTGGTAAAGCTGGTG 
>MN5P1-H6 - 1:2 SNP ratios – aneuploid or tri- or tetraploid 
TGAGCTATACATGAAGCACCAAGGTGTTGTAGAGGATRCATCGAATTCAGA
AGAGTTTCAGTTTTCAAAGAATTTCAAAAAGAGGCTTTCACAATACGCTCC
GAGTGTACTTTCAACATATTCCGATGATTCTGATTATGAGRCTCCTCGAATT
 145 
CCAGAAGGTGTTGCTATTGTGAAAGGTGAAGAGATGAATGCCAATTTTGGT
GGTTTGAGATTTGTTTTGATTGGTGATGTATCAGAATTGCCTGTCCTTGATA
TGAAAATCAAACCTTTTGAAGCACGAGCAATTAACTGGTCMACGGATCTTA
ATGCTGAGGTACATATTGAGCATTATATAAATATATTCAATTATGCACGATC
ATCTTGGGAGCCATTGGTTGAAAGTTGGCCAATAGCAGTTTACATGTCAAA
ATCCCGACACCCAAAGCCTCAATTATTAGTAGAGGTGATTTCTAGACAGGT
AGCTCAAGTGACGCTTACATCCAAAGCAGTAGCATTGCTATCTCAAGTATC
CGATTTGATTACTTCCRGAGAAAAATTAAAACCAAGAGGTGAAGATTACCC
ATACGTKATAGTGAATGAGACTSGTTTAGATTTGGAAGTTTGGAATGATGC
AAAWGAATYCGAAACCAAAACTGGAATCAAATCATGGGATTCTAAACCTT
GGAGCTTTGAGGACTG 
>MN5P1-H7 – Candida dubliniensis 
GCTTTTGATAATATTGATGTTAATGATGTTATATTGGGTCAATATACTAAAT
CAGAAGATGGTACCAAACCAGGTTATTTAGATGATAAAACGGTGAATCCTG
ATTCTAAAGCTGTTACTTATGCTGCTTTTAGAGTAAACATTCATAATGAAAG
ATGGGATGGTGTTCCAATTGTTTTACGTGCTGGTAAAGCTTTAGATGAAAGT
AAAGTTGAAATTAGAATTCAATTTAAACCTGTTGCTAAAGGAATGTTTAAA
GAAATTCAAAGAAATGAATTAGTTATTAGAATACAACCAAATGAAGCAATT
TATTTAAAAATTAATTCAAAGATCCCCGGGATTTCTACTGAAACTTCTTTAA
CTGATTTAGATTTAACTTATGCTACTCGTTATTCAAAAGATTTTTGGATTCC
AGAAGCTTATGAAGCTTTAATTAGAGATTGTTATTTAGGTAATCATTCTAAT
TTTGTTAGAGATGATGAATTGGATGTTTCTTGGAAATTATTTACTCCATTAT
TAAAAGCAGTTGAAGATCCTGCTAATAAAATAGAATTACAATATTATCCTT
ATGGTTCAAAAGGTCCAAAAGATTTAAGAAAATATTTGAAAGATCATGGTT
ATATATTTAGTGATCCAGGT 
>SL4T1-H1 - first 130 bp ~20% background sequence 
TGATATTCCATTGGCYCCACCAGACAARATTTTGGGTATTTCTGAAGCTTAT
AACAATGATTCTAACCCTCAAAAAATCAATTTGGGGGTTGGTGCTTATAGA
GATAATTCYGGTAAACCAATTATTTTCCCATCAGTTAAAAAAGCTGAAGAA
ATTTTATTGGGTAAAGAAACTGAAAAGGAATATACTGCCATTGTTGGTTCC
AAAAATTTCCAATCAATTGTGAAAAATTTCATTTTCAACAATTCTAATAAAG
ATGCCAATGGTAAACAATTAATTGATGATGGTAGAATTGTTACTGCTCAAA
CCATCTCTGGTACTGGATCACTTAGAGTTATYGCTGATTYYTTGAATCGTTT
YTATTCTAACAAGAAAATTTTGGTTCCAAAACCAACTTGGGCTAATCATGTT
GCTGTTTTCAAA 
>SL4T1-H2 
CATATTTTGAGGTCATCTGTTGTTCAAACCTCTTATGGTGAAATTTTTGCTA
AACATAGAGAACCAAATTTGGAAATTATTCGTGAGGTTGTTGATTCCAAAC
ATATTGTTTTTGATGTGTTGGCACAATTCTTAATCAATCCAGACCCATGGGT
TGCCATTGCTGCCGCTGAAGTTTATGTCAGACGTTCATACCGTGCTTATGAT
TTGGGTAAAATTGAATATCATGTTAATGACAGACTTCCTATTGTTGAATGGA
AATTCAAGTTGGCTAATATGGGAGCCGCTGGTGTAAACGATGCTCAACAGG
CTGCTGCTGCCGGTGGCGATGATTCGACATCTATGAAACATGCAGCTTCTGT
GTCTGATTTGACCTTTGTTGTTGATTCTAAAACCGAGCATTCCACAAGAACT
GGTGTTTTAGCTCCAGCAAGACACTTGGATG 
>SL4T1-H3 – Candida dubliniensis 
TCAGGTGAGTGTATCCATAAAAGTGAAATACCAGGTTACACTATCCCAGAG
AATCCAAAGTTCACTCTTGGTAATTTGTTTGTGATAATTGGGGTCTTGTTGG
TTTGTGTTTTGGCAGTTGTCTCTCTCTTGAGAAATATTAGTGAGTCGGCCTT
GTTCAAGAAAAATGGGTATGAGCCATTGGATTCAGATCCTAGCGTCATGAA
 146 
TCAAAACTTTGAGCCTACAACATTGTCGTTTGAAGATATAAAGTATGAGGT
TGCTGGTGGTCGACAAATTTTGAATGGAGTCTTTGGGTTTGTAAAACCAAG
AGAATGTTTGGCAATAATGGGGGGTTCGGGTGCTGGTAAAACTACGTTATT
GGATATTTTGGCCGGTAAGAACAAGGATGGTATGATTAATGGATCGATTTA
TGTTAATGGAAATCCAATAGACCCAAAACATTACAGATCTATTATCGGGT 
>SL4T1-H4 – Candida dubliniensis 
TTGGCTAAAACTTTGACTACAGTTCCTGAATTAAACGAAATTATTGGTCAAG
AATTGGTTGATGAATTTGTTAGTGGTATTAGACTACCAGCAGAAATTGGAA
GTCAAGATGATGTTAACAATAGAAAATTGTTACAAAAAGTGTTTGGTAAAT
TAATGAACACCAATGAAGATATTATAAAGCAACAAACTACTAAATTACTTG
AAAGAACAGAAAGGGAACCTCAAGTGTTTAAAAACATTGATTCTAGATTAC
CAGAGTTAATACAAAGATTGAACAAGCAATTTCCTAATGATATTGGATTAT
TTTGTGGATGTCTCTTGTTGAACCACGTTGGCTTGAACAAAGGGGAAGCAA
TGTTTTTACAAGCCAAAGACCCTCATGCATATATTAGTGGTGATATAATTGA 
>SL4T1-H5 – Candida dubliniensis plus ~10% Candida albicans 
TGAATTTGAACAAGAAATCGATGCTGCTGCAAGTTTACCATTTGGTGTTGTC
AAGGAATCTAAATCCAAGGAATTAGGGGTTGCGTTAAAGAAATTATCAATT
TCCGTATTGGATAAACAAAGATTAACTGAAAAATTCAATAAATTGGATAAA
TCAATCAAAGATAGTTTGAAGGCTAGACAAAAAGAGGAAACCAAAAAGAC
ATTGGATGTAGTTAACAATTGGTTGAATGATAAAGAAAATGCTTCATCATTT
TTGGTTGCTCATGTTCCAATTACTGCTAATGCAAAGGCAATTACTGAAGCTA
TTAACTTGATCAAAAAGCAAGACAAATCTAAATCAATTTATTTGTTGACCG
GCGAAACCGATAAAGTTGCTCATGGATGTTATGTTAGTGATGAAGCTATTG
CCAAGGGAATTAATGCCAATGAGTTAGCTAAGGCTGTATCTGAAAACATTG
GTGGTAAAGCTGGTG 
>SL4T1-H6 
TGAGCTATACATGAAGCACCAAGGTGTTGTAGAGGATGCATCGAATTCAGA
AGAGTTTCAGTTTTCAAAGAATTTCAAAAAGAGGCTTTCACAATACGCTCC
GAGTGTACTTTCAACATATTCCGATGATTCTGATTATGAGGCTCCTCGAATT
CCAGAAGGTGTTGCTATTGTGAAAGGTGAAGAGATGAATGCCAATTTTGGT
GGTTTGAGATTTGTTTTGATTGGTGATGTATCAGAATTGCCTGTCCTTGATA
TGAAAATCAAACCTTTTGAAGCACGAGCAATTAACTGGTCCACGGATCTTA
ATGCTGAGGTACATATTGAGCATTATATAAATATATTCAATTATGCACGATC
ATCTTGGGAGCCATTGGTTGAAAGTTGGCCAATAGCAGTTTACATGTCAAA
ATCCCGACACCCAAAGCCTCAATTATTAGTAGAGGTGATTTCTAGACAGGT
AGCTCAAGTGACGCTTACATCCAAAGCGGTAGCATTGCTATCTCAAGTATC
CGATTTGATTACTTCCGGAGAAAAATTAAAACCAAGAGGTGAAGATTACCC
ATACGTTATAGTGAATGAGACTGGTTTAGATTTGGAAGTTTGGAATGATGC
AAATGAATCCGAAACCAAAACTGGAATCAAATCATGGGATTCTAAACCTTG
GAGCTTTGAGGACTG 
>SL4T1-H7 – Candida dubliniensis 
GCTTTTGATAATATTGATGTTAATGATGTTATATTGGGTCAATATACTAAAT
CAGAAGATGGTACCAAACCAGGTTATTTAGATGATAAAACRGTGAATCCTG
ATTCTAAAGCTGTTACTTATGCTGCTTTTAGAGTAAACATTCATAATGAAAG
ATGGGATGGTGTTCCAATTGTTTTACGTGCTGGTAAAGCTTTAGATGAAAGT
AAAGTTGAAATTAGAATTCAATTTAAACCTGTTGCTAAAGGAATGTTTAAA
GAAATTCAAAGAAATGAATTAGTTATTAGAATACAACCAAATGAAGCAATT
TATTTAAAAATTAATTCAAAAATCCCCGGGATTTCTACTGAAACTTCTTTAA
CTGATTTAGATTTAACTTATGCTACTCGTTATTCAAAAGATTTTTGGATTCC
AGAAGCTTATGAAGCTTTAATTAGAGATTGTTATTTAGGTAATCATTCTAAT
 147 
TTTGTTAGAGATGATGAATTGGATGTTTCTTGGAAATTATTTACTCCATTAT
TAAAAGCAGTTGAAGATCCTGCTAATAAAATAGAATTACAATAYTATCCTT
ATGGTTCAAAAGGTCCAAAAGATTTAAGAAAATATTTGAAAGATCATGGTT
ATATATTTAGTGATCCAGGT 
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